Page last updated: 2024-08-01 08:26:59
ubiquinone 9
Description
ubiquinone 9: a form of coenzyme Q found in many foods; RN given refers to (all-E)-isomer [MeSH]
ubiquinone-9 : no description available [CHeBI]
Cross-References
Synonyms (51)
Synonym |
coq9 |
coenzyme q9 |
2,3-dimethoxy-5-methyl-6-[(2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl]-1,4-benzoquinone |
CHEBI:18160 , |
2,3-dimethoxy-5-methyl-6-[(2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl]cyclohexa-2,5-diene-1,4-dione |
(all-e)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-2,5-cyclohexadiene-1,4-dione |
ubiquinone q(sub 9) |
nsc 226993 |
p-benzoquinone, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)- |
2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-, (all-e)- |
p-benzoquinone, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)- (van) |
coq(sub 9) |
brn 1900081 |
coenzyme q(sub 9) |
C01967 |
ubiquinone-9 , |
303-97-9 |
coenzyme q(9) |
ubiquinone-45 |
nsc-226993 |
ubiquinone 9 |
nsc226993 |
ubiquinone 45 |
ubiquinone q9 |
p-benzoquinone,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)- |
2,4-dione, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-, (all-e)- |
LMPR02010004 |
coenzyme-q9 |
ubiquinone(9) |
coenzyme q9, >=96.0% (hplc) |
2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-((2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-yl)- |
2,3-dimethoxy-5-methyl-6-[(2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]cyclohexa-2,5-diene-1,4-dione |
4-08-00-03313 (beilstein handbook reference) |
unii-mgw7tyf2dq |
mgw7tyf2dq , |
CHEMBL2252965 |
ubiquinone q9 (stn) |
ubidecarenone impurity d [ep impurity] |
mfcd00056635 |
AKOS027307694 |
2-methyl-3-nonaprenyl-5,6-dimethoxy-1,4-benzoquinone |
ubidecarenone impurity d, european pharmacopoeia (ep) reference standard |
J-017946 |
CS-6359 |
HY-101415 |
Q27102857 |
2,3-dimethoxy-5-methyl-6-((2e,6e,10e,14e,18e,22e,26e,30e)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl)cyclohexa-2,5-diene-1,4-dione |
ubiquinone q9;coq9;ubiquinone 9 |
DTXSID601317880 |
AS-77794 |
ubiquinone9 |
Roles (2)
Role | Description |
antioxidant | A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides. |
human metabolite | Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens). |
Drug Classes (1)
Class | Description |
ubiquinones | Any benzoquinone derived from 2,3-dimethoxy-5-methylbenzoquinone; one of a group of naturally occurring homologues. The redox-active quinoid moiety usually carries a polyprenoid side chain at position 6, the number of isoprenoid units in which is species-specific. Ubiquinones are involved in the control of mitochondrial electron transport, and are also potent anti-oxidants. |
Pathways (2)
ubiquinone 9 is involved in 2 pathway(s), involving a total of 3 unique proteins and 23 unique compounds
Bioassays (4)
Assay ID | Title | Year | Journal | Article |
AID1091127 | Antifeedant activity against Coptotermes formosanus placed on 1 % wt/wt compound treated filter paper assessed as filter paper consumption measured 21 days post compound exposure (Rvb = 85 +/- 15.1 mg) | 2008 | Journal of agricultural and food chemistry, Jun-11, Volume: 56, Issue:11 ISSN: 0021-8561 | Activity of 1,4-benzoquinones against formosan subterranean termites (Coptotermes formosanus). |
AID1091095 | Termiticidal activity against Coptotermes formosanus placed on 1 % wt/wt compound treated filter paper assessed as termite mortality measured 11 days post compound exposure | 2008 | Journal of agricultural and food chemistry, Jun-11, Volume: 56, Issue:11 ISSN: 0021-8561 | Activity of 1,4-benzoquinones against formosan subterranean termites (Coptotermes formosanus). |
AID1091094 | Termiticidal activity against Coptotermes formosanus placed on 1 % wt/wt compound treated filter paper assessed as termite mortality measured 21 days post compound exposure | 2008 | Journal of agricultural and food chemistry, Jun-11, Volume: 56, Issue:11 ISSN: 0021-8561 | Activity of 1,4-benzoquinones against formosan subterranean termites (Coptotermes formosanus). |
AID1091096 | Termiticidal activity against Coptotermes formosanus placed on 1 % wt/wt compound treated filter paper assessed as termite mortality measured 3 days post compound exposure | 2008 | Journal of agricultural and food chemistry, Jun-11, Volume: 56, Issue:11 ISSN: 0021-8561 | Activity of 1,4-benzoquinones against formosan subterranean termites (Coptotermes formosanus). |
Research
Studies (227)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 18 (7.93) | 18.7374 |
1990's | 37 (16.30) | 18.2507 |
2000's | 69 (30.40) | 29.6817 |
2010's | 91 (40.09) | 24.3611 |
2020's | 12 (5.29) | 2.80 |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 2 (0.82%) | 5.53% |
Reviews | 3 (1.23%) | 6.00% |
Case Studies | 3 (1.23%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 236 (96.72%) | 84.16% |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
benzyl alcohol | | benzyl alcohols | antioxidant; fragrance; metabolite; solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gallic acid | | trihydroxybenzoic acid | antineoplastic agent; antioxidant; apoptosis inducer; astringent; cyclooxygenase 2 inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; geroprotector; human xenobiotic metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydrolipoic acid | | thio-fatty acid | antioxidant; human metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydrogen | | elemental hydrogen; elemental molecule; gas molecular entity | antioxidant; electron donor; food packaging gas; fuel; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydroquinone | | benzenediol; hydroquinones | antioxidant; carcinogenic agent; cofactor; Escherichia coli metabolite; human xenobiotic metabolite; mouse metabolite; skin lightening agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylserotonin | | acetamides; N-acylserotonin; phenols | antioxidant; human metabolite; mouse metabolite; tropomyosin-related kinase B receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
niacinamide | | pyridine alkaloid; pyridinecarboxamide; vitamin B3 | anti-inflammatory agent; antioxidant; cofactor; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; Escherichia coli metabolite; geroprotector; human urinary metabolite; metabolite; mouse metabolite; neuroprotective agent; Saccharomyces cerevisiae metabolite; Sir2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pqq cofactor | | orthoquinones; pyrroloquinoline cofactor; tricarboxylic acid | anti-inflammatory agent; antioxidant; cofactor; water-soluble vitamin (role) | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
putrescine | | alkane-alpha,omega-diamine | antioxidant; fundamental metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
spermine | | polyazaalkane; tetramine | antioxidant; fundamental metabolite; immunosuppressive agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
taurine | | amino sulfonic acid; zwitterion | antioxidant; Escherichia coli metabolite; glycine receptor agonist; human metabolite; mouse metabolite; nutrient; radical scavenger; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vanillin | | benzaldehydes; monomethoxybenzene; phenols | anti-inflammatory agent; anticonvulsant; antioxidant; flavouring agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isopentenyl pyrophosphate | | prenol phosphate | antigen; antioxidant; epitope; Escherichia coli metabolite; mouse metabolite; phosphoantigen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methoxytryptamine | | aromatic ether; primary amino compound; tryptamines | 5-hydroxytryptamine 2A receptor agonist; 5-hydroxytryptamine 2B receptor agonist; 5-hydroxytryptamine 2C receptor agonist; antioxidant; cardioprotective agent; human metabolite; mouse metabolite; neuroprotective agent; radiation protective agent; serotonergic agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7,8-dihydroxyflavone | | dihydroxyflavone | antidepressant; antineoplastic agent; antioxidant; plant metabolite; tropomyosin-related kinase B receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amifostine anhydrous | | diamine; organic thiophosphate | antioxidant; prodrug; radiation protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benphothiamine | | aminopyrimidine; formamides; organic phosphate; thioester | antioxidant; immunological adjuvant; nutraceutical; protective agent; provitamin B1 | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
berberine | | alkaloid antibiotic; berberine alkaloid; botanical anti-fungal agent; organic heteropentacyclic compound | antilipemic drug; antineoplastic agent; antioxidant; EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor; EC 1.21.3.3 (reticuline oxidase) inhibitor; EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.11.10 (IkappaB kinase) inhibitor; EC 3.1.1.4 (phospholipase A2) inhibitor; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor; EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; geroprotector; hypoglycemic agent; metabolite; potassium channel blocker | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
caffeic acid | | catechols; hydroxycinnamic acid | antioxidant; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; EC 2.5.1.18 (glutathione transferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carcinine | | beta-alanine derivative; imidazoles; monocarboxylic acid amide; organonitrogen compound; organooxygen compound | antioxidant; crustacean metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ebselen | | benzoselenazole | anti-inflammatory drug; antibacterial agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antioxidant; apoptosis inducer; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; EC 3.5.4.1 (cytosine deaminase) inhibitor; EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor; enzyme mimic; ferroptosis inhibitor; genotoxin; hepatoprotective agent; neuroprotective agent; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
idebenone | | 1,4-benzoquinones; primary alcohol | antioxidant; ferroptosis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
edaravone | | pyrazolone | antioxidant; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
molsidomine | | ethyl ester; morpholines; oxadiazole; zwitterion | antioxidant; apoptosis inhibitor; cardioprotective agent; nitric oxide donor; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
masoprocol | | catechols; lignan; tetrol | antioxidant; ferroptosis inhibitor; geroprotector; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
probucol | | dithioketal; polyphenol | anti-inflammatory drug; anticholesteremic drug; antilipemic drug; antioxidant; cardiovascular drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
resveratrol | | polyphenol; resorcinols; stilbenol | antioxidant; geroprotector; glioma-associated oncogene inhibitor; phytoalexin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sulforaphane | | isothiocyanate; sulfoxide | antineoplastic agent; antioxidant; EC 3.5.1.98 (histone deacetylase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,2'-thiodiethanol | | aliphatic sulfide; diol | antineoplastic agent; antioxidant; metabolite; solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
troglitazone | | chromanes; thiazolidinone | anticoagulant; anticonvulsant; antineoplastic agent; antioxidant; EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; hypoglycemic agent; platelet aggregation inhibitor; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zonisamide | | 1,2-benzoxazoles; sulfonamide | anticonvulsant; antioxidant; central nervous system drug; protective agent; T-type calcium channel blocker | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phlorhizin | | aryl beta-D-glucoside; dihydrochalcones; monosaccharide derivative | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methylene blue | | organic chloride salt | acid-base indicator; antidepressant; antimalarial; antimicrobial agent; antioxidant; cardioprotective agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 4.6.1.2 (guanylate cyclase) inhibitor; fluorochrome; histological dye; neuroprotective agent; physical tracer | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
medroxyprogesterone acetate | | 20-oxo steroid; 3-oxo-Delta(4) steroid; acetate ester; corticosteroid; steroid ester | adjuvant; androgen; antineoplastic agent; antioxidant; female contraceptive drug; inhibitor; progestin; synthetic oral contraceptive | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n,n'-diphenyl-4-phenylenediamine | | N-substituted diamine; secondary amino compound | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4-di-tert-butylphenol | | alkylbenzene; phenols | antioxidant; bacterial metabolite; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lactobionic acid | | disaccharide | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl gallate | | gallate ester | anti-inflammatory agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-terpinene | | cyclohexadiene; monoterpene | antioxidant; human xenobiotic metabolite; plant metabolite; volatile oil component | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-isopropyl-n-phenyl-4-phenylenediamine | | N-substituted diamine | allergen; antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-tert-butyl-4-hydroxyanisole | | aromatic ether; phenols | antioxidant; human xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl vanillin | | aromatic ether; benzaldehydes; phenols | antioxidant; flavouring agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
catechin | | catechin | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
triethylenediamine | | bridged compound; diamine; saturated organic heterobicyclic parent; tertiary amino compound | antioxidant; catalyst; reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiazolidine-4-carboxylic acid | | alpha-amino acid zwitterion; non-proteinogenic alpha-amino acid; sulfur-containing amino acid; thiazolidinemonocarboxylic acid | antidote; antioxidant; hepatoprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methylcatechol | | methylcatechol | antioxidant; carcinogenic agent; hapten; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thymoquinone | | 1,4-benzoquinones | adjuvant; anti-inflammatory agent; antidepressant; antineoplastic agent; antioxidant; cardioprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxyphenylethanol | | phenols | anti-arrhythmia drug; antioxidant; cardiovascular drug; fungal metabolite; geroprotector; plant metabolite; protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol | | terpineol; tertiary alcohol | anti-inflammatory agent; antibacterial agent; antineoplastic agent; antioxidant; antiparasitic agent; apoptosis inducer; plant metabolite; volatile oil component | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diphenylamine | | aromatic amine; bridged diphenyl fungicide; secondary amino compound | antifungal agrochemical; antioxidant; carotogenesis inhibitor; EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitor; ferroptosis inhibitor; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetylcysteine | | acetylcysteine; L-cysteine derivative; N-acetyl-L-amino acid | antidote to paracetamol poisoning; antiinfective agent; antioxidant; antiviral drug; ferroptosis inhibitor; geroprotector; human metabolite; mucolytic; radical scavenger; vulnerary | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydroferulic acid | | guaiacols; monocarboxylic acid; phenylpropanoid | antioxidant; human xenobiotic metabolite; mouse metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
d-alpha tocopherol | | alpha-tocopherol | algal metabolite; antiatherogenic agent; anticoagulant; antioxidant; antiviral agent; EC 2.7.11.13 (protein kinase C) inhibitor; immunomodulator; micronutrient; nutraceutical; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diallyl trisulfide | | organic trisulfide | anti-inflammatory agent; antilipemic drug; antineoplastic agent; antioxidant; antiprotozoal drug; apoptosis inducer; estrogen receptor antagonist; insecticide; platelet aggregation inhibitor; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl vanillate | | aromatic ether; benzoate ester; phenols | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zingerone | | methyl ketone; monomethoxybenzene; phenols | anti-inflammatory agent; antiemetic; antioxidant; flavouring agent; fragrance; plant metabolite; radiation protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
butylated hydroxytoluene | | phenols | antioxidant; ferroptosis inhibitor; food additive; geroprotector | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,6-di-tert-butylphenol | | alkylbenzene; phenols | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
silybin | | aromatic ether; benzodioxine; flavonolignan; polyphenol; secondary alpha-hydroxy ketone | antineoplastic agent; antioxidant; hepatoprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | | chromanol; monocarboxylic acid; phenols | antioxidant; ferroptosis inhibitor; neuroprotective agent; radical scavenger; Wnt signalling inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oltipraz | | 1,2-dithiole; pyrazines | angiogenesis modulating agent; antimutagen; antineoplastic agent; antioxidant; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor; neurotoxin; protective agent; schistosomicide drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
baicalin | | dihydroxyflavone; glucosiduronic acid; glycosyloxyflavone; monosaccharide derivative | antiatherosclerotic agent; antibacterial agent; anticoronaviral agent; antineoplastic agent; antioxidant; cardioprotective agent; EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; ferroptosis inhibitor; neuroprotective agent; non-steroidal anti-inflammatory drug; plant metabolite; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epigallocatechin gallate | | flavans; gallate ester; polyphenol | antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylaspartic acid | | N-acetyl-L-amino acid; N-acyl-L-aspartic acid | antioxidant; human metabolite; mouse metabolite; nutraceutical; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gallocatechol | | gallocatechin | antioxidant; metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
salvin | | abietane diterpenoid; carbotricyclic compound; catechols; monocarboxylic acid | angiogenesis modulating agent; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; food preservative; HIV protease inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-hydroxydehydroepiandrosterone | | 17-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; 7alpha-hydroxy steroid; androstanoid | anti-inflammatory agent; antioxidant; estrogen; human xenobiotic metabolite; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pinocembrin | | (2S)-flavan-4-one; dihydroxyflavanone | antineoplastic agent; antioxidant; metabolite; neuroprotective agent; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epicatechin | | catechin; polyphenol | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gallocatechol | | catechin; flavan-3,3',4',5,5',7-hexol | antioxidant; food component; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hesperetin | | 3'-hydroxyflavanones; 4'-methoxyflavanones; monomethoxyflavanone; trihydroxyflavanone | antineoplastic agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vexibinol | | (2S)-flavan-4-one; 4'-hydroxyflavanones; tetrahydroxyflavanone | antimalarial; antimicrobial agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pinobanksin | | secondary alpha-hydroxy ketone; trihydroxyflavanone | antimutagen; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
brazilin | | catechols; organic heterotetracyclic compound; tertiary alcohol | anti-inflammatory agent; antibacterial agent; antineoplastic agent; antioxidant; apoptosis inducer; biological pigment; hepatoprotective agent; histological dye; NF-kappaB inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
madecassic acid | | monocarboxylic acid; pentacyclic triterpenoid; tetrol | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fangchinoline | | aromatic ether; bisbenzylisoquinoline alkaloid; macrocycle | anti-HIV-1 agent; anti-inflammatory agent; antineoplastic agent; antioxidant; neuroprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
corilagin | | ellagitannin; gallate ester | antihypertensive agent; antioxidant; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
arjunolic acid | | hydroxy monocarboxylic acid; pentacyclic triterpenoid | antibacterial agent; antifungal agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
maslinic acid | | dihydroxy monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory agent; antineoplastic agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl protocatechuate | | catechols; ethyl ester | antibacterial agent; antioxidant; apoptosis inducer; EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
decane-1,2-diol | | glycol; volatile organic compound | anti-inflammatory agent; antioxidant; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dihydroxyphenylethanol | | catechols; primary alcohol | antineoplastic agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
eriocitrin | | 3'-hydroxyflavanones; 4'-hydroxyflavanones; disaccharide derivative; flavanone glycoside; rutinoside; trihydroxyflavanone | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dihydroxymandelic acid | | 2-hydroxy monocarboxylic acid; catechols | antioxidant; drug metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sugiol | | abietane diterpenoid; carbotricyclic compound; cyclic terpene ketone; meroterpenoid; phenols | antineoplastic agent; antioxidant; antiviral agent; plant metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sesaminol | | benzodioxoles; furofuran; organic hydroxy compound | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
wr 1065 | | alkanethiol; diamine | antioxidant; drug metabolite; radiation protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cafestol | | diterpenoid; furans; organic heteropentacyclic compound; primary alcohol; tertiary alcohol | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; hypoglycemic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kahweol | | diterpenoid; furans; organic heteropentacyclic compound; primary alcohol; tertiary alcohol | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
celastrol | | monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory drug; antineoplastic agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Hsp90 inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
procyanidin b2 | | biflavonoid; hydroxyflavan; polyphenol; proanthocyanidin | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
proanthocyanidin a2 | | hydroxyflavan; proanthocyanidin | angiogenesis modulating agent; anti-HIV agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
swertisin | | dihydroxyflavone; flavone C-glycoside; monomethoxyflavone; monosaccharide derivative; polyphenol | adenosine A1 receptor antagonist; anti-inflammatory agent; antioxidant; hypoglycemic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rubiadin | | dihydroxyanthraquinone | antibacterial agent; antioxidant; hepatoprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyanidin | | 5-hydroxyanthocyanidin | antioxidant; metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ovothiol c | | aryl thiol; L-alpha-amino acid zwitterion; L-histidine derivative | antioxidant; marine metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ovothiol a | | aryl thiol; L-alpha-amino acid zwitterion; L-histidine derivative; non-proteinogenic L-alpha-amino acid | antioxidant; marine metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman | | benzopyran | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
eckol | | phlorotannin | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
procyanidin b3 | | biflavonoid; hydroxyflavan; polyphenol; proanthocyanidin | anti-inflammatory agent; antioxidant; EC 2.3.1.48 (histone acetyltransferase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
schizandrin b | | aromatic ether; cyclic acetal; organic heterotetracyclic compound; oxacycle; tannin | anti-asthmatic agent; anti-inflammatory agent; antilipemic drug; antioxidant; apoptosis inhibitor; hepatoprotective agent; nephroprotective agent; neuroprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acrovestone | | acetophenones; aromatic ether; olefinic compound; polyphenol | antioxidant; EC 1.14.18.1 (tyrosinase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4'-demethyldesoxypodophyllotoxin | | furonaphthodioxole; gamma-lactone; lignan; methoxybenzenes; phenols | antineoplastic agent; antioxidant; immunosuppressive agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ampelopsin | | dihydromyricetin; secondary alpha-hydroxy ketone | antineoplastic agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
secoxyloganin | | beta-D-glucoside; dicarboxylic acid monoester; enoate ester; methyl ester; monosaccharide derivative; pyrans; secoiridoid glycoside | anti-allergic agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pectolinarin | | dimethoxyflavone; disaccharide derivative; glycosyloxyflavone; monohydroxyflavanone; rutinoside | anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
procyanidin C1 | | hydroxyflavan; polyphenol; proanthocyanidin | anti-inflammatory agent; antioxidant; EC 1.17.3.2 (xanthine oxidase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; lipoxygenase inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,5-dihydroxybenzyl alcohol | | aromatic primary alcohol; phenols | antineoplastic agent; antioxidant; apoptosis inhibitor; fungal metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sitosterol, (3beta)-isomer | | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; C29-steroid; phytosterols; stigmastane sterol | anticholesteremic drug; antioxidant; mouse metabolite; plant metabolite; sterol methyltransferase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
erythritol | | butane-1,2,3,4-tetrol | antioxidant; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl 3,4-dihydroxybenzoate | | catechols; methyl ester | antioxidant; neuroprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sorbinil | | azaspiro compound; chromanes; imidazolidinone; organofluorine compound; oxaspiro compound | antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dihydroxyphenylpropionic acid | | (dihydroxyphenyl)propanoic acid | antioxidant; human xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylneuraminic acid | | N-acetylneuraminic acids | antioxidant; bacterial metabolite; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carnosine | | amino acid zwitterion; dipeptide | anticonvulsant; antineoplastic agent; antioxidant; Daphnia magna metabolite; geroprotector; human metabolite; mouse metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
allose | | allopyranose; D-allose | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
peonidin | | 5-hydroxyanthocyanidin | antineoplastic agent; antioxidant; apoptosis inducer; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ginsenoside re | | 12beta-hydroxy steroid; 3beta-hydroxy-4,4-dimethylsteroid; 3beta-hydroxy steroid; beta-D-glucoside; disaccharide derivative; ginsenoside; tetracyclic triterpenoid | anti-inflammatory agent; antineoplastic agent; antioxidant; nephroprotective agent; neuroprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
notoginsenoside r1 | | 12beta-hydroxy steroid; 3beta-hydroxy-4,4-dimethylsteroid; 3beta-hydroxy steroid; beta-D-glucoside; disaccharide derivative; ginsenoside; tetracyclic triterpenoid | antioxidant; apoptosis inducer; neuroprotective agent; phytoestrogen; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
stevioside | | beta-D-glucoside; bridged compound; diterpene glycoside; ent-kaurane diterpenoid; tetracyclic diterpenoid | anti-inflammatory agent; antineoplastic agent; antioxidant; hypoglycemic agent; plant metabolite; sweetening agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
davidigenin | | dihydrochalcones; polyphenol | anti-allergic agent; anti-asthmatic agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
genipin | | iridoid monoterpenoid | anti-inflammatory agent; antioxidant; apoptosis inhibitor; cross-linking reagent; hepatotoxic agent; uncoupling protein inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isonaringin | | (2S)-flavan-4-one; 4'-hydroxyflavanones; dihydroxyflavanone; disaccharide derivative; rutinoside | anti-inflammatory agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
knipholone | | aromatic ketone; dihydroxyanthraquinone; methoxybenzenes; methyl ketone; polyphenol; resorcinols | antineoplastic agent; antioxidant; antiplasmodial drug; leukotriene antagonist; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha bitter acid | | aromatic ketone; cyclic ketone; diketone; tertiary alpha-hydroxy ketone; triol | antibacterial drug; antioxidant; cyclooxygenase 2 inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
solasodine | | alkaloid antibiotic; azaspiro compound; hemiaminal ether; oxaspiro compound; sapogenin; steroid alkaloid | anticonvulsant; antifungal agent; antiinfective agent; antioxidant; antipyretic; antispermatogenic agent; apoptosis inducer; cardiotonic drug; central nervous system depressant; diuretic; immunomodulator; plant metabolite; teratogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
petunidin-3-glucoside | | anthocyanin cation; aromatic ether; beta-D-glucoside | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tretinoin | | retinoic acid; vitamin A | anti-inflammatory agent; antineoplastic agent; antioxidant; AP-1 antagonist; human metabolite; keratolytic drug; retinoic acid receptor agonist; retinoid X receptor agonist; signalling molecule | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
equilenin | | 17-oxo steroid; 3-hydroxy steroid | antioxidant; mammalian metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
resveratrol | | resveratrol | antioxidant; phytoalexin; plant metabolite; quorum sensing inhibitor; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oleic acid | | octadec-9-enoic acid | antioxidant; Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; Escherichia coli metabolite; mouse metabolite; plant metabolite; solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ferulic acid | | ferulic acids | anti-inflammatory agent; antioxidant; apoptosis inhibitor; cardioprotective agent; MALDI matrix material; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lycopene | | acyclic carotene | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pallidol | | carbopolycyclic compound; polyphenol; stilbenoid | antifungal agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
riboflavin | | flavin; vitamin B2 | anti-inflammatory agent; antioxidant; cofactor; Escherichia coli metabolite; food colouring; fundamental metabolite; human urinary metabolite; mouse metabolite; photosensitizing agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
piperlactam s | | alkaloid; aromatic ether; gamma-lactam; organic heterotetracyclic compound; phenols | anti-inflammatory agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hydroxycinnamic acid | | 2-coumaric acid; phenols | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
beta-ionone | | ionone | antioxidant; fragrance | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
propylthiouracil | | pyrimidinethione | antidote to paracetamol poisoning; antimetabolite; antioxidant; antithyroid drug; carcinogenic agent; EC 1.14.13.39 (nitric oxide synthase) inhibitor; hormone antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isoferulic acid | | ferulic acids | antioxidant; biomarker; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aurapten | | coumarins; monoterpenoid | antihypertensive agent; antineoplastic agent; antioxidant; apoptosis inducer; dopaminergic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; gamma-secretase modulator; gastrointestinal drug; hepatoprotective agent; matrix metalloproteinase inhibitor; neuroprotective agent; plant metabolite; PPARalpha agonist; vulnerary | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiourea | | one-carbon compound; thioureas; ureas | antioxidant; chromophore | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
u 0126 | | aryl sulfide; dinitrile; enamine; substituted aniline | antineoplastic agent; antioxidant; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; osteogenesis regulator; vasoconstrictor agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ferrostatin-1 | | ethyl ester; primary arylamine; substituted aniline | antifungal agent; antioxidant; ferroptosis inhibitor; neuroprotective agent; radiation protective agent; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sb 415286 | | C-nitro compound; maleimides; monochlorobenzenes; phenols; secondary amino compound; substituted aniline | antioxidant; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fraxetin | | aromatic ether; hydroxycoumarin | anti-inflammatory agent; antibacterial agent; antimicrobial agent; antioxidant; apoptosis inducer; apoptosis inhibitor; Arabidopsis thaliana metabolite; hepatoprotective agent; hypoglycemic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercetin 3-o-glucuronide | | beta-D-glucosiduronic acid; quercetin O-glycoside | antidepressant; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercetin | | 7-hydroxyflavonol; pentahydroxyflavone | antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bilirubin | | biladienes; dicarboxylic acid | antioxidant; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sinapine | | acylcholine | antioxidant; photosynthetic electron-transport chain inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7,3'-dihydroxy-4'-methoxyisoflavone | | 4'-methoxyisoflavones; 7-hydroxyisoflavones | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercitrin | | alpha-L-rhamnoside; monosaccharide derivative; quercetin O-glycoside; tetrahydroxyflavone | antileishmanial agent; antioxidant; EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.14.18.1 (tyrosinase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
beta carotene | | carotenoid beta-end derivative; cyclic carotene | antioxidant; biological pigment; cofactor; ferroptosis inhibitor; human metabolite; mouse metabolite; plant metabolite; provitamin A | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
retinol palmitate | | all-trans-retinyl ester; retinyl palmitate | antioxidant; Escherichia coli metabolite; human xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
luteolin-7-glucoside | | beta-D-glucoside; glycosyloxyflavone; monosaccharide derivative; trihydroxyflavone | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chrysoeriol | | monomethoxyflavone; trihydroxyflavone | antineoplastic agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercetin 3-o-glucopyranoside | | beta-D-glucoside; monosaccharide derivative; quercetin O-glucoside; tetrahydroxyflavone | antineoplastic agent; antioxidant; antipruritic drug; bone density conservation agent; geroprotector; histamine antagonist; osteogenesis regulator; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rutin | | disaccharide derivative; quercetin O-glucoside; rutinoside; tetrahydroxyflavone | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zeaxanthin | | carotenol | antioxidant; bacterial metabolite; cofactor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
butein | | chalcones; polyphenol | antineoplastic agent; antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor; geroprotector; hypoglycemic agent; plant metabolite; radiosensitizing agent; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
astaxanthine | | carotenol; carotenone | animal metabolite; anticoagulant; antioxidant; food colouring; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gardenia yellow | | diester; disaccharide derivative; diterpenoid | antioxidant; food colouring; histological dye; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cryptoxanthins | | carotenol | antioxidant; biomarker; plant metabolite; provitamin A | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
esculetin | | hydroxycoumarin | antioxidant; plant metabolite; ultraviolet filter | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
esculin | | beta-D-glucoside; hydroxycoumarin | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oleuropein | | beta-D-glucoside; catechols; diester; methyl ester; pyrans; secoiridoid glycoside | anti-inflammatory agent; antihypertensive agent; antineoplastic agent; antioxidant; apoptosis inducer; NF-kappaB inhibitor; nutraceutical; plant metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
baicalein | | trihydroxyflavone | angiogenesis inhibitor; anti-inflammatory agent; antibacterial agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antioxidant; apoptosis inducer; EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; EC 4.1.1.17 (ornithine decarboxylase) inhibitor; ferroptosis inhibitor; geroprotector; hormone antagonist; plant metabolite; prostaglandin antagonist; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chrysin | | 7-hydroxyflavonol; dihydroxyflavone | anti-inflammatory agent; antineoplastic agent; antioxidant; EC 2.7.11.18 (myosin-light-chain kinase) inhibitor; hepatoprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diosmetin | | 3'-hydroxyflavonoid; monomethoxyflavone; trihydroxyflavone | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; bone density conservation agent; cardioprotective agent; plant metabolite; tropomyosin-related kinase B receptor agonist; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diosmin | | dihydroxyflavanone; disaccharide derivative; glycosyloxyflavone; monomethoxyflavone; rutinoside | anti-inflammatory agent; antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fisetin | | 3'-hydroxyflavonoid; 7-hydroxyflavonol; tetrahydroxyflavone | anti-inflammatory agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
demethylbellidifolin | | tetrol; xanthones | antioxidant; EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite; mutagen; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hispidulin | | monomethoxyflavone; trihydroxyflavone | anti-inflammatory agent; anticonvulsant; antineoplastic agent; antioxidant; apoptosis inducer; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mangiferin | | C-glycosyl compound; xanthones | anti-inflammatory agent; antioxidant; hypoglycemic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mangostin | | aromatic ether; phenols; xanthones | antimicrobial agent; antineoplastic agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,2,8-trihydroxy-6-methoxyxanthone | | aromatic ether; polyphenol; xanthones | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
morin | | 7-hydroxyflavonol; pentahydroxyflavone | angiogenesis modulating agent; anti-inflammatory agent; antibacterial agent; antihypertensive agent; antineoplastic agent; antioxidant; EC 5.99.1.2 (DNA topoisomerase) inhibitor; hepatoprotective agent; metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
myricetin | | 7-hydroxyflavonol; hexahydroxyflavone | antineoplastic agent; antioxidant; cyclooxygenase 1 inhibitor; food component; geroprotector; hypoglycemic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
norwogonin | | trihydroxyflavone | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
orientin | | 3'-hydroxyflavonoid; C-glycosyl compound; tetrahydroxyflavone | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
patuletin | | flavonols; monomethoxyflavone; pentahydroxyflavone | analgesic; antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor; lipoxygenase inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercetagetin | | flavonols; hexahydroxyflavone | antioxidant; antiviral agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rhamnetin | | monomethoxyflavone; tetrahydroxyflavone | anti-inflammatory agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
robustaflavone | | biflavonoid; hydroxyflavone; ring assembly | anti-HBV agent; antineoplastic agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tamarixetin | | 7-hydroxyflavonol; monomethoxyflavone; tetrahydroxyflavone | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
coumestrol | | coumestans; delta-lactone; polyphenol | anti-inflammatory agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
astringin | | beta-D-glucoside; monosaccharide derivative; polyphenol; stilbenoid | antineoplastic agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
polydatin | | beta-D-glucoside; monosaccharide derivative; polyphenol; stilbenoid | anti-arrhythmia drug; antioxidant; geroprotector; hepatoprotective agent; metabolite; nephroprotective agent; potassium channel modulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pterostilbene | | diether; methoxybenzenes; stilbenol | anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; hypoglycemic agent; neuroprotective agent; neurotransmitter; plant metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
caffeic acid phenethyl ester | | alkyl caffeate ester | anti-inflammatory agent; antibacterial agent; antineoplastic agent; antioxidant; antiviral agent; immunomodulator; metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ellagic acid | | catechols; cyclic ketone; lactone; organic heterotetracyclic compound; polyphenol | antioxidant; EC 1.14.18.1 (tyrosinase) inhibitor; EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor; EC 2.4.1.1 (glycogen phosphorylase) inhibitor; EC 2.5.1.18 (glutathione transferase) inhibitor; EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor; EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor; EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; food additive; fungal metabolite; geroprotector; plant metabolite; skin lightening agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
coenzyme q10 | | ubiquinones | antioxidant; ferroptosis inhibitor; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercimeritrin | | beta-D-glucoside; flavonols; monosaccharide derivative; quercetin O-glucoside; tetrahydroxyflavone | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercetin-3-o-sophoroside | | sophoroside; tetrahydroxyflavone | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-tocotrienol | | tocotrienol; vitamin E | antineoplastic agent; antioxidant; apoptosis inducer; hepatoprotective agent; plant metabolite; radiation protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
menatetrenone | | menaquinone | anti-inflammatory agent; antioxidant; bone density conservation agent; human metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nk 104 | | calcium salt; statin (synthetic) | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pitavastatin | | cyclopropanes; dihydroxy monocarboxylic acid; monofluorobenzenes; quinolines; statin (synthetic) | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenretinide | | monocarboxylic acid amide; retinoid | antineoplastic agent; antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rosmarinic acid | | carboxylic ester; monocarboxylic acid; phenylpropanoid; polyphenol | antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor; non-steroidal anti-inflammatory drug; peripheral nervous system drug; plant metabolite; serine proteinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cannabigerol | | phytocannabinoid; resorcinols | anti-inflammatory agent; antibacterial agent; antioxidant; appetite enhancer; cannabinoid receptor agonist; neuroprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quadrangularin a | | indanes; polyphenol; stilbenoid | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isosalipurposide | | beta-D-glucoside; chalcones; monosaccharide derivative; resorcinols | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
icariin | | flavonols; glycosyloxyflavone | antioxidant; bone density conservation agent; EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; phytoestrogen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sappanchalcone | | catechols; chalcones; monomethoxybenzene | anti-allergic agent; anti-inflammatory agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methylesculetin | | hydroxycoumarin | anti-inflammatory agent; antioxidant; hyaluronan synthesis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
spiraeoside | | beta-D-glucoside; flavonols; monosaccharide derivative; quercetin O-glucoside; tetrahydroxyflavone | antineoplastic agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside | | beta-D-glucoside; resorcinols; stilbenoid | anti-inflammatory agent; antioxidant; apoptosis inhibitor; cardioprotective agent; cyclooxygenase 2 inhibitor; platelet aggregation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ag-490 | | catechols; enamide; monocarboxylic acid amide; nitrile; secondary carboxamide | anti-inflammatory agent; antioxidant; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; geroprotector; STAT3 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ergothioneine | | 1,3-dihydroimidazole-2-thiones; amino-acid betaine; L-histidine derivative; sulfur-containing amino acid | antioxidant; chelator; fungal metabolite; plant metabolite; xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
molsidomine | | ethyl ester; morpholines; oxadiazole; zwitterion | antioxidant; apoptosis inhibitor; cardioprotective agent; nitric oxide donor; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monomethyl fumarate | | dicarboxylic acid monoester; enoate ester; methyl ester | antioxidant; drug metabolite; immunomodulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5,4'-dihydroxy-7,3'-dimethoxyflavone | | dihydroxyflavone; dimethoxyflavone | anti-allergic agent; anti-inflammatory agent; antibacterial agent; antioxidant; melanin synthesis inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercetin 3-sambubioside | | disaccharide derivative; quercetin O-glucoside; tetrahydroxyflavone | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
germacrone | | germacrane sesquiterpenoid; olefinic compound | androgen antagonist; anti-inflammatory agent; antifeedant; antifungal agent; antimicrobial agent; antineoplastic agent; antioxidant; antitussive; antiviral agent; apoptosis inducer; autophagy inducer; hepatoprotective agent; insecticide; neuroprotective agent; plant metabolite; volatile oil component | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
meso-zeaxanthin | | carotenol | anti-inflammatory agent; antioxidant; human xenobiotic metabolite; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
salvianolic acid B | | 1-benzofurans; catechols; dicarboxylic acid; enoate ester; polyphenol | anti-inflammatory agent; antidepressant; antineoplastic agent; antioxidant; apoptosis inducer; autophagy inhibitor; cardioprotective agent; hepatoprotective agent; hypoglycemic agent; neuroprotective agent; osteogenesis regulator; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trilobatin | | aryl beta-D-glucoside; dihydrochalcones; monosaccharide derivative | anti-inflammatory agent; antioxidant; plant metabolite; sweetening agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
capsiate | | carboxylic ester; monomethoxybenzene; phenols | angiogenesis inhibitor; anti-allergic agent; anti-inflammatory agent; antioxidant; capsaicin receptor agonist; hypoglycemic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tln 4601 | | dibenzodiazepine; farnesane sesquiterpenoid; olefinic compound; secondary amine; triol | antineoplastic agent; antioxidant; cathepsin L (EC 3.4.22.15) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
arachidonoylserotonin | | N-acylserotonin; phenols | anti-inflammatory agent; anticonvulsant; antioxidant; capsaicin receptor antagonist; EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor; human metabolite; signalling molecule | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nigerloxin | | aromatic ether; benzamides; benzoic acids; phenols; styrenes | antioxidant; Aspergillus metabolite; EC 1.1.1.21 (aldehyde reductase) inhibitor; lipoxygenase inhibitor; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-phloroeckol | | aromatic ether; phlorotannin | antioxidant; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aspalathin | | C-glycosyl compound; catechols; dihydrochalcones; polyketide; polyphenol | antioxidant; EC 1.17.3.2 (xanthine oxidase) inhibitor; hypoglycemic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glyceryl ferulate | | 1-monoglyceride; aromatic ether; enoate ester; phenols | antioxidant; plant metabolite; ultraviolet filter | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(+)-dehydrodiconiferyl alcohol | | dehydrodiconiferyl alcohol | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ginsenoside rb3 | | 12beta-hydroxy steroid; beta-D-glucoside; disaccharide derivative; ginsenoside; tetracyclic triterpenoid | antidepressant; antioxidant; cardioprotective agent; neuroprotective agent; NMDA receptor antagonist; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
astragaloside IV | | pentacyclic triterpenoid; triterpenoid saponin | anti-inflammatory agent; antioxidant; EC 4.2.1.1 (carbonic anhydrase) inhibitor; neuroprotective agent; plant metabolite; pro-angiogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-O-feruloyl-beta-D-glucose | | aromatic ether; beta-D-glucoside; cinnamate ester; phenols | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alx-0600 | | polypeptide | antioxidant; glucagon-like peptide-2 receptor agonist; metabolite; protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyranonigrin a | | cyclic ketone; enol; gamma-lactam; pyranopyrrole; secondary alcohol | antioxidant; Aspergillus metabolite; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
madecassoside | | carboxylic ester; pentacyclic triterpenoid; trisaccharide derivative; triterpenoid saponin | anti-inflammatory agent; antioxidant; antirheumatic drug; plant metabolite; vulnerary | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bacillithiol | | glycoside; monosaccharide derivative; thiol | antioxidant; bacterial metabolite; cofactor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kurarinol | | 4'-hydroxyflavanones; monomethoxyflavanone; trihydroxyflavanone | anti-inflammatory agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(20R)-ginsenoside Rg3 | | ginsenoside; glycoside; tetracyclic triterpenoid | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hispidin | | 2-pyranones; catechols | antioxidant; EC 2.7.11.13 (protein kinase C) inhibitor; fungal metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oleuropein aglycone | | catechols; diester; lactol; methyl ester; pyrans; secoiridoid | anti-inflammatory agent; antioxidant; mTOR inhibitor; neuroprotective agent; plant metabolite; TRPA1 channel agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
staphyloxanthin | | apo carotenoid triterpenoid; D-aldohexose derivative; fatty acid ester; triol; xanthophyll | antioxidant; biological pigment; metabolite; virulence factor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-hydroxy-2,4,5-triaminopyrimidine | | aminopyrimidine; hydroxypyrimidine | antioxidant; chromophore | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
liproxstatin-1 | | azaspiro compound; monochlorobenzenes; organic heterotricyclic compound; secondary amino compound | antioxidant; cardioprotective agent; ferroptosis inhibitor; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetylcarnitine | | O-acylcarnitine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-oxo-3-methylvalerate | | 2-oxo monocarboxylic acid; branched-chain keto acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha-ketoisovalerate | | 2-oxo monocarboxylic acid; branched-chain keto acid | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,3-diphosphoglycerate | | bisphosphoglyceric acid; tetronic acid derivative | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-keto-4-methylvalerate | | 2-oxo monocarboxylic acid; branched-chain keto acid | algal metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxyanthranilic acid | | aminobenzoic acid; monohydroxybenzoic acid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxykynurenine | | hydroxykynurenine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-oxoadipic acid | | dicarboxylic fatty acid; oxo dicarboxylic acid | bacterial xenobiotic metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-mercaptopyruvic acid | | 2-oxo monocarboxylic acid; thiol | antidote to cyanide poisoning; Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phosphoserine | | non-proteinogenic alpha-amino acid; O-phosphoamino acid; serine derivative | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-phenylpropionic acid | | benzenes; monocarboxylic acid | antifungal agent; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-aminobutyric acid | | amino acid zwitterion; gamma-amino acid; monocarboxylic acid | human metabolite; neurotransmitter; Saccharomyces cerevisiae metabolite; signalling molecule | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxyphenylacetic acid | | monocarboxylic acid; phenols | fungal metabolite; human metabolite; mouse metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isocaproaldehyde | | alpha-CH2-containing aldehyde | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aminolevulinic acid | | 4-oxo monocarboxylic acid; amino acid zwitterion; delta-amino acid | antineoplastic agent; dermatologic drug; Escherichia coli metabolite; human metabolite; mouse metabolite; photosensitizing agent; plant metabolite; prodrug; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-aminovaleric acid | | amino acid zwitterion; delta-amino acid; omega-amino fatty acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-hydroxytryptophan | | hydroxytryptophan | human metabolite; neurotransmitter | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetaldehyde | | aldehyde | carcinogenic agent; EC 3.5.1.4 (amidase) inhibitor; electron acceptor; Escherichia coli metabolite; human metabolite; mouse metabolite; mutagen; oxidising agent; Saccharomyces cerevisiae metabolite; teratogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetone | | ketone body; methyl ketone; propanones; volatile organic compound | EC 3.5.1.4 (amidase) inhibitor; human metabolite; polar aprotic solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetyl phosphate | | acyl monophosphate | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
adenine | | 6-aminopurines; purine nucleobase | Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
allantoin | | imidazolidine-2,4-dione; ureas | Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite; vulnerary | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
anthranilic acid | | aminobenzoic acid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
beta-alanine | | amino acid zwitterion; beta-amino acid | agonist; fundamental metabolite; human metabolite; inhibitor; neurotransmitter | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
betaine aldehyde | | quaternary ammonium ion | Aspergillus metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-butanol | | alkyl alcohol; primary alcohol; short-chain primary fatty alcohol | human metabolite; mouse metabolite; protic solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ureidosuccinic acid | | aspartic acid derivative; C4-dicarboxylic acid; N-carbamoyl-amino acid | Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carbon monoxide | | carbon oxide; gas molecular entity; one-carbon compound | biomarker; EC 1.9.3.1 (cytochrome c oxidase) inhibitor; human metabolite; ligand; metabolite; mitochondrial respiratory-chain inhibitor; mouse metabolite; neurotoxin; neurotransmitter; P450 inhibitor; probe; signalling molecule; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carnitine | | amino-acid betaine | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
choline | | cholines | allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter; nutrient; plant metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chlorine | | halide anion; monoatomic chlorine | cofactor; Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
coumarin | | coumarins | fluorescent dye; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aminoethylphosphonic acid | | phosphonic acids; primary amino compound; zwitterion | human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
octanoic acid | | medium-chain fatty acid; straight-chain saturated fatty acid | antibacterial agent; Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trimethylenediamine | | alkane-alpha,omega-diamine | human metabolite; mouse metabolite; reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxybutyric acid | | (omega-1)-hydroxy fatty acid; 3-hydroxy monocarboxylic acid; hydroxybutyric acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methylmalonic acid | | C4-dicarboxylic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyrrolidonecarboxylic acid | | oxoproline; pyrrolidin-2-ones; pyrrolidinemonocarboxylic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dihydroxyphenylacetic acid | | catechols; dihydroxyphenylacetic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha-keto-delta-guanidinovaleric acid | | 2-oxo monocarboxylic acid; zwitterion | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
creatine | | glycine derivative; guanidines; zwitterion | geroprotector; human metabolite; mouse metabolite; neuroprotective agent; nutraceutical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cytosine | | aminopyrimidine; pyrimidine nucleobase; pyrimidone | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydrouracil | | pyrimidone | Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydrolipoamide | | dithiol; monocarboxylic acid amide | cofactor; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydroxyacetone phosphate | | glycerone phosphates; primary alpha-hydroxy ketone | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydroxyacetone | | ketotriose; primary alpha-hydroxy ketone | antifungal agent; Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dimethylglycine | | amino acid zwitterion; N-methyl-amino acid; N-methylglycines | Daphnia magna metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5,6-dimethylbenzimidazole | | dimethylbenzimidazole | Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethanolamine | | ethanolamines; primary alcohol; primary amine | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-butyrobetaine | | amino-acid betaine | Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glutaric acid | | alpha,omega-dicarboxylic acid; dicarboxylic fatty acid | Daphnia magna metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycerol | | alditol; triol | algal metabolite; detergent; Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha-glycerophosphoric acid | | glycerol monophosphate | algal metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycolaldehyde | | glycolaldehydes | fundamental metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glyoxylic acid | | 2-oxo monocarboxylic acid; aldehydic acid | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycocyamine | | guanidinoacetic acids; zwitterion | bacterial metabolite; human metabolite; mouse metabolite; nutraceutical; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydrogen cyanide | | hydracid; one-carbon compound | Escherichia coli metabolite; human metabolite; poison | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydrogen carbonate | | carbon oxoanion | cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
histamine | | aralkylamino compound; imidazoles | human metabolite; mouse metabolite; neurotransmitter | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
homogentisic acid | | dihydroxyphenylacetic acid; hydroquinones | human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
indole-3-acetaldehyde | | indoleacetaldehyde | bacterial metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
indoleacetic acid | | indole-3-acetic acids; monocarboxylic acid | auxin; human metabolite; mouse metabolite; plant hormone; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
itaconic acid | | dicarboxylic acid; dicarboxylic fatty acid; olefinic compound | fungal metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
potassium | | alkali metal cation; elemental potassium; monoatomic monocation; monovalent inorganic cation | cofactor; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydroxyphenylalanine | | hydroxyphenylalanine; non-proteinogenic alpha-amino acid; tyrosine derivative | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kynurenine | | aromatic ketone; non-proteinogenic alpha-amino acid; substituted aniline | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lipoamide | | dithiolanes; monocarboxylic acid amide | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
malonic acid | | alpha,omega-dicarboxylic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methylmercaptan | | alkanethiol | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyruvaldehyde | | 2-oxo aldehyde; propanals | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methanol | | alkyl alcohol; one-carbon compound; primary alcohol; volatile organic compound | amphiprotic solvent; Escherichia coli metabolite; fuel; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
melatonin | | acetamides; tryptamines | anticonvulsant; central nervous system depressant; geroprotector; hormone; human metabolite; immunological adjuvant; mouse metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-methylphenylethanolamine | | alkaloid; phenylethanolamines | human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n'-acetylspermine | | acetamides; acetylspermine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitrites | | monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydroxypyruvic acid | | 2-oxo monocarboxylic acid; 3-hydroxy monocarboxylic acid; primary alpha-hydroxy ketone | Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oxalic acid | | alpha,omega-dicarboxylic acid | algal metabolite; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxyphenylpyruvic acid | | 2-oxo monocarboxylic acid; phenols | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hexadecanal | | 2,3-saturated fatty aldehyde; long-chain fatty aldehyde | human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylacetaldehyde | | alpha-CH2-containing aldehyde; phenylacetaldehydes | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylacetic acid | | benzenes; monocarboxylic acid; phenylacetic acids | allergen; Aspergillus metabolite; auxin; EC 6.4.1.1 (pyruvate carboxylase) inhibitor; Escherichia coli metabolite; human metabolite; plant growth retardant; plant metabolite; Saccharomyces cerevisiae metabolite; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hydroxyphenethylamine | | phenylethanolamines | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenethylamine | | alkaloid; aralkylamine; phenylethylamine | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phosphoric acid | | phosphoric acids | algal metabolite; fertilizer; human metabolite; NMR chemical shift reference compound; solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phosphorylcholine | | phosphocholines | allergen; epitope; hapten; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phosphorylethanolamine | | phosphoethanolamine; primary amino compound | algal metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
picolinic acid | | pyridinemonocarboxylic acid | human metabolite; MALDI matrix material | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyridoxal | | hydroxymethylpyridine; methylpyridines; monohydroxypyridine; pyridinecarbaldehyde; vitamin B6 | cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyridoxal phosphate | | methylpyridines; monohydroxypyridine; pyridinecarbaldehyde; vitamin B6 phosphate | coenzyme; cofactor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyridoxamine | | aminoalkylpyridine; hydroxymethylpyridine; monohydroxypyridine; vitamin B6 | Escherichia coli metabolite; human metabolite; iron chelator; mouse metabolite; nephroprotective agent; plant metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyridoxamine phosphate | | aminoalkylpyridine; methylpyridines; monohydroxypyridine; vitamin B6 phosphate | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyridoxine | | hydroxymethylpyridine; methylpyridines; monohydroxypyridine; vitamin B6 | cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quinolinic acid | | pyridinedicarboxylic acid | Escherichia coli metabolite; human metabolite; mouse metabolite; NMDA receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiosulfates | | divalent inorganic anion; sulfur oxide; sulfur oxoanion | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sarcosine | | N-alkylglycine zwitterion; N-alkylglycine; N-methyl-amino acid; N-methylglycines | Escherichia coli metabolite; glycine receptor agonist; glycine transporter 1 inhibitor; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiamine | | primary alcohol; vitamin B1 | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thymine | | pyrimidine nucleobase; pyrimidone | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-methyl-1,3-thiazol-5-yl)ethanol | | 1,3-thiazoles; primary alcohol | Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tryptamine | | aminoalkylindole; aralkylamino compound; indole alkaloid; tryptamines | human metabolite; mouse metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
uracil | | pyrimidine nucleobase; pyrimidone | allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; prodrug; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
uric acid | | uric acid | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
urea | | isourea; monocarboxylic acid amide; one-carbon compound | Daphnia magna metabolite; Escherichia coli metabolite; fertilizer; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vanilmandelic acid | | 2-hydroxy monocarboxylic acid; aromatic ether; phenols | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
perillic acid | | alpha,beta-unsaturated monocarboxylic acid; cyclohexenecarboxylic acid | antineoplastic agent; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
meglutol | | 3-hydroxy carboxylic acid; dicarboxylic acid; tertiary alcohol | anticholesteremic drug; antimetabolite; EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
homovanillic acid | | guaiacols; monocarboxylic acid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxy-4-methoxyphenethylamine | | monomethoxybenzene; phenols; phenylethylamine; primary amino compound | human metabolite; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydroxyindoleacetic acid | | indole-3-acetic acids | drug metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cetyl alcohol | | hexadecanol; long-chain primary fatty alcohol | algal metabolite; flavouring agent; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-cresol | | cresol | Escherichia coli metabolite; human metabolite; uremic toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
debrisoquin | | carboxamidine; isoquinolines | adrenergic agent; antihypertensive agent; human metabolite; sympatholytic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
decanoic acid | | medium-chain fatty acid; straight-chain saturated fatty acid | algal metabolite; anti-inflammatory agent; antibacterial agent; human metabolite; plant metabolite; volatile oil component | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nordazepam | | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; GABA modulator; human metabolite; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,5-dihydroxybenzoic acid | | dihydroxybenzoic acid | EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; fungal metabolite; human metabolite; MALDI matrix material; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tele-methylhistamine | | imidazoles; primary amino compound | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
indolepropionic acid | | indol-3-yl carboxylic acid | auxin; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kynurenic acid | | monohydroxyquinoline; quinolinemonocarboxylic acid | G-protein-coupled receptor agonist; human metabolite; neuroprotective agent; nicotinic antagonist; NMDA receptor antagonist; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-phenyllactic acid | | 2-hydroxy monocarboxylic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-3-phosphonopropionic acid | | alanine derivative; non-proteinogenic alpha-amino acid; phosphonic acids | human metabolite; metabotropic glutamate receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-phenylglycine | | non-proteinogenic alpha-amino acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nifedipine | | C-nitro compound; dihydropyridine; methyl ester | calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oxidopamine | | benzenetriol; catecholamine; primary amino compound | drug metabolite; human metabolite; neurotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sebacic acid | | alpha,omega-dicarboxylic acid; dicarboxylic fatty acid | human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
stearic acid | | long-chain fatty acid; saturated fatty acid; straight-chain saturated fatty acid | algal metabolite; Daphnia magna metabolite; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
succinylacetone | | beta-diketone; dioxo monocarboxylic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tolbutamide | | N-sulfonylurea | human metabolite; hypoglycemic agent; insulin secretagogue; potassium channel blocker | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
retinoic acid | | alpha,beta-unsaturated monocarboxylic acid; retinoid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tyramine | | monoamine molecular messenger; primary amino compound; tyramines | EC 3.1.1.8 (cholinesterase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
corticosterone | | 11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
estriol | | 16alpha-hydroxy steroid; 17beta-hydroxy steroid; 3-hydroxy steroid | estrogen; human metabolite; human xenobiotic metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sorbitol | | glucitol | cathartic; Escherichia coli metabolite; food humectant; human metabolite; laxative; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite; sweetening agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thymidine | | pyrimidine 2'-deoxyribonucleoside | Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydroxyproline | | 4-hydroxyproline; L-alpha-amino acid zwitterion | human metabolite; mouse metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thyroxine | | 2-halophenol; iodophenol; L-phenylalanine derivative; non-proteinogenic L-alpha-amino acid; thyroxine zwitterion; thyroxine | antithyroid drug; human metabolite; mouse metabolite; thyroid hormone | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aldosterone | | 11beta-hydroxy steroid; 18-oxo steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid hormone; mineralocorticoid; primary alpha-hydroxy ketone; steroid aldehyde | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cysteine | | cysteine zwitterion; cysteine; L-alpha-amino acid; proteinogenic amino acid; serine family amino acid | EC 4.3.1.3 (histidine ammonia-lyase) inhibitor; flour treatment agent; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
estrone | | 17-oxo steroid; 3-hydroxy steroid; phenolic steroid; phenols | antineoplastic agent; bone density conservation agent; estrogen; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
androsterone | | 17-oxo steroid; 3alpha-hydroxy steroid; androstanoid; C19-steroid | androgen; anticonvulsant; human blood serum metabolite; human metabolite; human urinary metabolite; mouse metabolite; pheromone | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
etiocholanolone | | 17-oxo steroid; 3alpha-hydroxy steroid; androstanoid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dehydroepiandrosterone | | 17-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; androstanoid | androgen; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
triiodothyronine | | 2-halophenol; amino acid zwitterion; iodophenol; iodothyronine | human metabolite; mouse metabolite; thyroid hormone | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isonicotinic acid | | pyridinemonocarboxylic acid | algal metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
serine | | L-alpha-amino acid; proteinogenic amino acid; serine family amino acid; serine zwitterion; serine | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glutamine | | amino acid zwitterion; glutamine family amino acid; glutamine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid | EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lysine | | aspartate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; lysine; organic molecular entity; proteinogenic amino acid | algal metabolite; anticonvulsant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sucrose | | glycosyl glycoside | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; sweetening agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
adenosine diphosphate | | adenosine 5'-phosphate; purine ribonucleoside 5'-diphosphate | fundamental metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
uridine | | uridines | drug metabolite; fundamental metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
uridine monophosphate | | pyrimidine ribonucleoside 5'-monophosphate; uridine 5'-phosphate | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
levodopa | | amino acid zwitterion; dopa; L-tyrosine derivative; non-proteinogenic L-alpha-amino acid | allelochemical; antidyskinesia agent; antiparkinson drug; dopaminergic agent; hapten; human metabolite; mouse metabolite; neurotoxin; plant growth retardant; plant metabolite; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cysteamine | | amine; thiol | geroprotector; human metabolite; mouse metabolite; radiation protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leucine | | amino acid zwitterion; L-alpha-amino acid; leucine; proteinogenic amino acid; pyruvate family amino acid | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
androstenedione | | 17-oxo steroid; 3-oxo-Delta(4) steroid; androstanoid | androgen; Daphnia magna metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cytidine monophosphate | | cytidine 5'-phosphate; pyrimidine ribonucleoside 5'-monophosphate | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methionine | | aspartate family amino acid; L-alpha-amino acid; methionine zwitterion; methionine; proteinogenic amino acid | antidote to paracetamol poisoning; human metabolite; micronutrient; mouse metabolite; nutraceutical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
desoxycorticosterone | | 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; mineralocorticoid; primary alpha-hydroxy ketone | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cytidine | | cytidines | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
17-alpha-hydroxyprogesterone | | 17alpha-hydroxy-C21-steroid; 17alpha-hydroxy steroid; tertiary alpha-hydroxy ketone | human metabolite; metabolite; mouse metabolite; progestin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
asparagine | | amino acid zwitterion; asparagine; aspartate family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
histidine | | amino acid zwitterion; histidine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid | algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-pentanol | | pentanol; short-chain primary fatty alcohol | human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
valine | | L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; pyruvate family amino acid; valine | algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
threonine | | amino acid zwitterion; aspartate family amino acid; L-alpha-amino acid; proteinogenic amino acid; threonine | algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tryptophan | | erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; tryptophan zwitterion; tryptophan | antidepressant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isoleucine | | aspartate family amino acid; isoleucine; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethylamine | | primary aliphatic amine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
taurocholic acid | | amino sulfonic acid; bile acid taurine conjugate | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
skatole | | methylindole | human metabolite; mammalian metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quinaldic acid | | quinolinemonocarboxylic acid | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methylpentane | | alkane; volatile organic compound | allelochemical; human metabolite; non-polar solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methylcyclopentane | | cycloalkane; volatile organic compound | human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phosphoribosyl pyrophosphate | | 5-O-phosphono-D-ribofuranosyl diphosphate | Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-phenethylamine | | phenylethylamine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trehalose | | trehalose | Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isethionic acid | | alkanesulfonic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methylcyclohexane | | cycloalkane; volatile organic compound | aprotic solvent; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
piperidine | | azacycloalkane; piperidines; saturated organic heteromonocyclic parent; secondary amine | base; catalyst; human metabolite; non-polar solvent; plant metabolite; protic solvent; reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
undecanoic acid | | medium-chain fatty acid; straight-chain saturated fatty acid | antifungal agent; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-tridecanol | | long-chain primary fatty alcohol; tridecanol | bacterial metabolite; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
stearyl alcohol | | long-chain primary fatty alcohol; octadecanol | algal metabolite; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetol | | methyl ketone; primary alcohol; primary alpha-hydroxy ketone; propanones | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methylbutanoic acid | | methylbutyric acid | bacterial metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hexanoic acid | | medium-chain fatty acid; straight-chain saturated fatty acid | human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isopropyl palmitate | | fatty acid ester; isopropyl ester | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pregnenolone | | 20-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; C21-steroid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
20-alpha-dihydroprogesterone | | 20-hydroxypregn-4-en-3-one | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
homoarginine | | homoarginine; L-lysine derivative; non-proteinogenic L-alpha-amino acid | biomarker; EC 3.1.3.1 (alkaline phosphatase) inhibitor; human metabolite; rat metabolite; xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dibenzo(a,l)pyrene | | ortho- and peri-fused polycyclic arene | human metabolite; mutagen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diiodotyrosine | | diiodotyrosine; L-tyrosine derivative; non-proteinogenic L-alpha-amino acid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methoxytyrosine | | aromatic L-alpha-amino acid zwitterion; L-tyrosine derivative; monomethoxybenzene; non-proteinogenic L-alpha-amino acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiocyanate | | pseudohalide anion; sulfur molecular entity | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxyphenyllactic acid | | 2-hydroxy carboxylic acid; phenols | bacterial metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
citrulline | | amino acid zwitterion; citrulline | Daphnia magna metabolite; EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; protective agent; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lithocholic acid | | bile acid; C24-steroid; monohydroxy-5beta-cholanic acid | geroprotector; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nandrolone | | 17beta-hydroxy steroid; 3-oxo-Delta(4) steroid; anabolic androgenic steroid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
homocystine | | amino acid zwitterion; homocystines | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chenodeoxycholic acid | | bile acid; C24-steroid; dihydroxy-5beta-cholanic acid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycocholic acid | | bile acid glycine conjugate | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epitestosterone | | 17alpha-hydroxy steroid; 3-oxo-Delta(4) steroid; androstanoid | androgen antagonist; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ninhydrin | | aromatic ketone; beta-diketone; indanones; ketone hydrate | colour indicator; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
indican | | aryl sulfate; indoles | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
suberic acid | | alpha,omega-dicarboxylic acid; dicarboxylic fatty acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hexadecanedioic acid | | alpha,omega-dicarboxylic acid; dicarboxylic fatty acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
androstenediol | | 17beta-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid | androgen; human metabolite; mouse metabolite; radiation protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydrotestosterone | | 17beta-hydroxy steroid; 17beta-hydroxyandrostan-3-one; 3-oxo-5alpha-steroid | androgen; Daphnia magna metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyridoxamine dihydrochloride | | hydrochloride; vitamin B6 | Escherichia coli metabolite; human metabolite; iron chelator; mouse metabolite; nephroprotective agent; plant metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aceturic acid | | N-acetyl-amino acid; N-acylglycine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
myristic acid | | long-chain fatty acid; straight-chain saturated fatty acid | algal metabolite; Daphnia magna metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycylglycine | | dipeptide zwitterion; dipeptide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lignoceric acid | | straight-chain saturated fatty acid; very long-chain fatty acid | Daphnia tenebrosa metabolite; human metabolite; plant metabolite; volatile oil component | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
18-hydroxycorticosterone | | 11beta-hydroxy steroid; 18-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo steroid; primary alpha-hydroxy ketone | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hydroxybutyric acid | | 2-hydroxy monocarboxylic acid; hydroxybutyric acid | algal metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methylhexane | | alkane; volatile organic compound | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethylmalonic acid | | dicarboxylic acid; dicarboxylic fatty acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
galactitol | | hexitol | Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hydroxyphenylacetic acid | | hydroxy monocarboxylic acid; phenols | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methyl-2-furfural | | aldehyde; furans | EC 2.2.1.6 (acetolactate synthase) inhibitor; flavouring agent; human metabolite; Maillard reaction product | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hexanol | | hexanol; secondary alcohol | human metabolite; plant metabolite; semiochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,1,3,3-tetramethylurea | | ureas | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycochenodeoxycholic acid | | bile acid glycine conjugate | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isocaproic acid | | branched-chain saturated fatty acid; medium-chain fatty acid; methyl-branched fatty acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dehydroepiandrosterone sulfate | | 17-oxo steroid; steroid sulfate | EC 2.7.1.33 (pantothenate kinase) inhibitor; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
homoserine | | amino acid zwitterion; homoserine | algal metabolite; Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dodecanedioic acid | | alpha,omega-dicarboxylic acid; dicarboxylic fatty acid | EC 1.1.1.1 (alcohol dehydrogenase) inhibitor; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deoxycytidine | | pyrimidine 2'-deoxyribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deoxyuridine | | pyrimidine 2'-deoxyribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2'-deoxyadenosine | | purine 2'-deoxyribonucleoside; purines 2'-deoxy-D-ribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cytidine diphosphate choline | | nucleotide-(amino alcohol)s; phosphocholines | human metabolite; mouse metabolite; neuroprotective agent; psychotropic drug; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-pentene-3-one | | enone | flavouring agent; genotoxin; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5 alpha-androstane-3 alpha,17 beta-diol | | androstane-3alpha,17beta-diol | Daphnia magna metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
9,10-epoxystearic acid | | epoxystearic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-hydroxyindole | | hydroxyindoles | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
beta-hydroxymyristic acid | | 3-hydroxy fatty acid; 3-hydroxy monocarboxylic acid; long-chain fatty acid | bacterial metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
perillaldehyde | | aldehyde; olefinic compound | human metabolite; mouse metabolite; volatile oil component | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tricosanoic acid | | straight-chain saturated fatty acid; very long-chain fatty acid | Daphnia magna metabolite; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
uridine diphosphate glucuronic acid | | UDP-D-glucuronic acid | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tetrahydropapaveroline | | benzylisoquinoline alkaloid; benzyltetrahydroisoquinoline; isoquinolinol | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dithiothreitol | | 1,4-dimercaptobutane-2,3-diol; butanediols; dithiol; glycol; thiol | chelator; human metabolite; reducing agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyclic cmp | | 3',5'-cyclic pyrimidine nucleotide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
furoylglycine | | furans; N-acylglycine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,3',5'-triiodothyronine | | iodothyronine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
limonene | | cycloalkene; p-menthadiene | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hypochlorous acid | | chlorine oxoacid; reactive oxygen species | EC 2.5.1.18 (glutathione transferase) inhibitor; EC 3.1.1.7 (acetylcholinesterase) inhibitor; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
urobilinogen | | bilanes | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
estetrol | | 15alpha-hydroxy steroid; 16alpha-hydroxy steroid; 17beta-hydroxy steroid; 3-hydroxy steroid; steroid hormone | estrogen receptor agonist; estrogen; human metabolite; human xenobiotic metabolite; oral contraceptive | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
iron | | divalent metal cation; iron cation; monoatomic dication | cofactor; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-methyladenosine | | methyladenosine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
iodine | | halide anion; monoatomic iodine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nonanal | | medium-chain fatty aldehyde; n-alkanal; saturated fatty aldehyde | human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dimethylacetamide | | acetamides; monocarboxylic acid amide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ursodeoxycholic acid | | bile acid; C24-steroid; dihydroxy-5beta-cholanic acid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pregnanolone | | 3-hydroxy-5beta-pregnan-20-one; 3alpha-hydroxy steroid | human metabolite; intravenous anaesthetic; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s-adenosylmethionine | | sulfonium betaine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetylgalactosamine | | N-acetyl-D-hexosamine; N-acetylgalactosamine | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
paclitaxel | | taxane diterpenoid; tetracyclic diterpenoid | antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
norsalsolinol | | isoquinolinol | animal metabolite; apoptosis inducer; human metabolite; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline | | isoquinolinol; tertiary amino compound | human metabolite; neurotoxin; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
adenosine | | adenosines; purines D-ribonucleoside | analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
d-lactic acid | | 2-hydroxypropanoic acid | Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xanthosine | | purines D-ribonucleoside; xanthosines | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,5-anhydroglucitol | | anhydro sugar | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methylhistidine | | L-histidine derivative; non-proteinogenic L-alpha-amino acid; zwitterion | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methylcytosine | | methylcytosine; pyrimidines | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deoxyuridine triphosphate | | deoxyuridine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-triphosphate | Arabidopsis thaliana metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
homocitrulline | | amino acid zwitterion; L-lysine derivative; non-proteinogenic L-alpha-amino acid; ureas | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cholesteryl sulfate | | steroid sulfate | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2'-deoxycytidine 5'-triphosphate | | 2'-deoxycytidine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-triphosphate | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
25-hydroxycholesterol | | 25-hydroxy steroid; oxysterol | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aica ribonucleotide | | 1-(phosphoribosyl)imidazolecarboxamide; aminoimidazole | cardiovascular drug; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylserine | | acetyl-L-serine; N-acetyl-L-amino acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
o-4-methylthymine | | aromatic ether; methylthymine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tetraiodothyroacetic acid | | 2-halophenol; aromatic ether; iodophenol; monocarboxylic acid | apoptosis inducer; human metabolite; thyroid hormone | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lathosterol | | 3beta-sterol; C27-steroid; cholestanoid; Delta(7)-sterol | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
omega-aminocaprylic acid | | medium-chain fatty acid; omega-amino fatty acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methoxyestradiol | | 17beta-hydroxy steroid; 3-hydroxy steroid | angiogenesis modulating agent; antimitotic; antineoplastic agent; human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
parabanic acid | | hydracid; imidazolidinone | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetyl-l-arginine | | N-acetyl-L-amino acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cystine | | cystine zwitterion; cystine; L-cysteine derivative; non-proteinogenic L-alpha-amino acid | EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-methyladenine | | 6-alkylaminopurine; methyladenine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylacetylglycine | | monocarboxylic acid amide; monocarboxylic acid; N-acylglycine | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydracrylic acid | | 3-hydroxy monocarboxylic acid; omega-hydroxy-short-chain fatty acid | Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hordenine | | phenethylamine alkaloid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methoxyestradiol | | 17beta-hydroxy steroid; 3-hydroxy steroid; aromatic ether; phenols | estrogen; human metabolite; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glutaurine | | dipeptide zwitterion; dipeptide; L-glutamine derivative; sulfonic acid | anticonvulsant; anxiolytic drug; hormone; human metabolite; mammalian metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
plasmenylserine | | O-phosphoserine | EC 1.4.7.1 [glutamate synthase (ferredoxin)] inhibitor; EC 2.5.1.49 (O-acetylhomoserine aminocarboxypropyltransferase) inhibitor; EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ubiquinone-o | | ubiquinones | Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
beta-hydroxyisovaleric acid | | 3-hydroxy monocarboxylic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylhistamine | | acetamides; imidazoles | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
indole-3-carboxylic acid | | indol-3-yl carboxylic acid | bacterial metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-hydroxymethylcytosine | | aminopyrimidine; aromatic primary alcohol; nucleobase analogue; pyrimidone | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylglutamic acid | | N-acetyl-L-amino acid; N-acyl-L-glutamic acid | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,5-dihydroxybenzaldehyde | | dihydroxybenzaldehyde | human metabolite; mouse metabolite; Penicillium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
D-serine | | D-alpha-amino acid; serine zwitterion; serine | Escherichia coli metabolite; human metabolite; NMDA receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
D-alanine | | alanine zwitterion; alanine; D-alpha-amino acid | EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor; Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-ketopentanoic acid | | 2-oxo monocarboxylic acid; oxopentanoic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydroxyindoleacetaldehyde | | hydroxyindoles; indoleacetaldehyde | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leucylleucine | | dipeptide; L-aminoacyl-L-amino acid zwitterion | human metabolite; Mycoplasma genitalium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-hydroxymethyluracil | | primary alcohol; pyrimidone | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
12-hydroxydodecanoic acid | | omega-hydroxy-medium-chain fatty acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl sulfate | | aryl sulfate; C-nitro compound | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glucose-1,6-bisphosphate | | D-glucose 1,6-bisphosphate | Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
biotinamide | | biotins; monocarboxylic acid amide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxymandelic acid | | 2-hydroxy monocarboxylic acid; phenols | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylalanine | | L-alanine derivative; N-acetyl-L-amino acid | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
17-alpha-hydroxypregnenolone | | 17alpha-hydroxy-C21-steroid; 17alpha-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid; hydroxypregnenolone; tertiary alpha-hydroxy ketone | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cholest-4-en-3-one | | 3-oxo-Delta(4) steroid; cholestanoid | human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mephentermine | | 2-aminooctadecane-1,3-diol | EC 2.7.11.13 (protein kinase C) inhibitor; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-pinene oxide | | epoxide; pinane monoterpenoid | bacterial xenobiotic metabolite; fragrance; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-methylhistidine | | L-histidine derivative; non-proteinogenic L-alpha-amino acid; zwitterion | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxybutyric acid | | 3-hydroxybutyric acid; ketone body | fungal metabolite; human metabolite; pheromone | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
L-2-aminoadipic acid | | 2-aminoadipic acid | Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
testosterone acetate | | 3-oxo-Delta(4) steroid; androstanoid; sterol ester | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylacetylglutamine | | N(2)-phenylacetylglutamine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5beta-pregnane-3,20-dione | | 20-oxo steroid; 3-oxo-5beta-steroid; C21-steroid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zymosterol | | 3beta-sterol; cholestanoid | human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
brexanolone | | 3-hydroxy-5alpha-pregnan-20-one | antidepressant; GABA modulator; human metabolite; intravenous anaesthetic; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-alpha-dihydroprogesterone | | 20-oxo steroid; 3-oxo-5alpha-steroid; C21-steroid hormone | human metabolite; progestogen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-epsilon-acetyllysine | | acetyl-L-lysine; amino acid zwitterion; N(6)-acyl-L-lysine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hydroxyhexadecanoic acid | | 2-hydroxy fatty acid; hydroxypalmitic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
19-oxo-delta(4) androstene-3,17-dione | | 17-oxo steroid; 19-oxo steroid; 3-oxo-Delta(4) steroid; androstanoid; steroid aldehyde | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-glutamylglutamate | | dipeptide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
indole-3-lactic acid | | hydroxy monocarboxylic acid; indol-3-yl carboxylic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n(alpha)-acetyllysine | | acetyl-L-lysine; amino acid zwitterion | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycyl-l-phenylalanine | | dipeptide zwitterion; dipeptide | human metabolite; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5,6-dihydrothymine | | pyrimidone | human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-glutamyltyrosine | | dicarboxylic acid; dipeptide; phenols; primary amino compound; secondary carboxamide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cholest-5-ene-3 beta,26-diol | | 26-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid; oxysterol | EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hydroxyisovaleric acid | | 2-hydroxy monocarboxylic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aminomalonic acid | | amino dicarboxylic acid | Daphnia magna metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zymostenol | | 3beta-sterol; cholestanoid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
16-hydroxydehydroepiandrosterone | | 16alpha-hydroxy steroid; 17-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; androstanoid; secondary alpha-hydroxy ketone | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cortisol 21-sulfate | | 11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 3-oxo-Delta(4) steroid; cortisol ester; steroid sulfate; tertiary alpha-hydroxy ketone | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,2-distearoylphosphatidylethanolamine | | phosphatidylethanolamine zwitterion; phosphatidylethanolamine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydrogen sulfite | | sulfur oxoanion | human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aflatoxin b1-2,3-oxide | | aflatoxin | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fructose 2,6-diphosphate | | D-fructofuranose 2,6-bisphosphate | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pregnenolone sulfate | | steroid sulfate | EC 2.7.1.33 (pantothenate kinase) inhibitor; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,3'-diiodothyronine | | 3,3'-diiodothyronine; amino acid zwitterion | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
l-lactic acid | | (2S)-2-hydroxy monocarboxylic acid; 2-hydroxypropanoic acid | Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
propionylcarnitine | | O-acylcarnitine | analgesic; antirheumatic drug; cardiotonic drug; human metabolite; peripheral nervous system drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hypotaurine | | aminosulfinic acid; zwitterion | human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
testosterone 17-glucosiduronate | | 3-oxo steroid; beta-D-glucosiduronic acid; enone; steroid glucosiduronic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-chloro-L-tyrosine | | chloroamino acid; L-alpha-amino acid zwitterion; L-tyrosine derivative; monochlorobenzenes; non-proteinogenic L-alpha-amino acid | biomarker; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
androsterone glucuronide | | beta-D-glucosiduronic acid; steroid glucosiduronic acid | human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
selenomethylselenocysteine | | non-proteinogenic alpha-amino acid; selenocysteines | antineoplastic agent; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,5(10)-estradiene-3,4,17-trione | | 17-oxo steroid; 3-oxo-Delta(1) steroid; orthoquinones | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s-sulphocysteine | | organic thiosulfate; S-substituted L-cysteine | human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
estrone-3-glucuronide | | 17-oxo steroid; beta-D-glucosiduronic acid; steroid glucosiduronic acid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dihydroxyphenylacetaldehyde | | alpha-CH2-containing aldehyde; catechols; phenylacetaldehydes | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
caprylates | | fatty acid anion 8:0; straight-chain saturated fatty acid anion | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-hydroxyethyl radical | | organic anion | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(20s)-20-hydroxycholesterol | | 20-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid; oxysterol | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deoxyhypusine | | L-lysine derivative; non-proteinogenic L-alpha-amino acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,7,12-trihydroxycoprostanic acid | | 12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid; cholestanoic acid; hydroxy monocarboxylic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
triiodothyronine sulfate | | aryl sulfate; O-sulfoamino acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,7,12-trihydroxycholestan-26-oic acid | | 12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid; hydroxy monocarboxylic acid; steroid acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
erythrose 4-phosphate | | erythrose phosphate | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n(8)-acetylspermidine | | acetylspermidine | Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7 alpha-hydroxy-4-cholesten-3-one | | 3-oxo-Delta(4) steroid; 7alpha-hydroxy steroid; cholestanoid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pristanic acid | | branched-chain saturated fatty acid; long-chain fatty acid; methyl-branched fatty acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-glutamylcysteine | | gamma-glutamylcysteine | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
27-hydroxycholesterol | | 26-hydroxycholesterol | apoptosis inducer; human metabolite; mouse metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-carboxy-4-methyl-5-propyl-2-furanpropionic acid | | dicarboxylic acid; furoic acid | human metabolite; uremic toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dehydroalanine | | 2,3-dehydroamino acid; alpha,beta-unsaturated monocarboxylic acid; amino acid zwitterion; enamine; non-proteinogenic alpha-amino acid | alkylating agent; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hypothiocyanite ion | | one-carbon compound; sulfur oxoacid | antibacterial agent; antifungal agent; antiviral agent; human metabolite; oxidising agent; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-c-methylerythritol | | tetritol | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
succinylacetoacetate | | alpha,omega-dicarboxylic acid; beta-diketone | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isoursodeoxycholic acid | | dihydroxy-5beta-cholanic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mannitol-1-phosphate | | alditol 1-phosphate; hexitol phosphate | Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
triiodothyronine | | tetrahydrothiophenes; thiolactone | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kinetensin | | oligopeptide | histamine releasing agent; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
estra-1(10),4-diene-2,3,17-trione | | 17-oxo steroid; 3-oxo-Delta(4) steroid; orthoquinones | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2'-deoxycytidine diphosphate | | 2'-deoxycytidine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-diphosphate | Escherichia coli metabolite; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-methylserotonin | | phenols; tryptamines | human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-glutamylglutamine | | dipeptide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dihydroxybutanoic acid | | 3-hydroxy fatty acid; omega-hydroxy-short-chain fatty acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-palmitoylglycine | | fatty amide; N-acylglycine 16:0 | human metabolite; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-glutamyl-leucine | | glutamyl-L-amino acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ribulose | | ribulose | Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dihydroxyphenylglycolaldehyde | | catechols; hydroxyaldehyde | human metabolite; mouse metabolite; neurotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
androsterone sulfate | | 17-oxo steroid; androstanoid; steroid sulfate | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,7,12-trihydroxycoprostane | | 12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
saccharopine | | amino acid opine; L-lysine derivative | human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
allysine | | allysine; amino acid zwitterion; aminoadipate semialdehyde; non-proteinogenic L-alpha-amino acid | human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
orotidylic acid | | pyrimidine ribonucleoside 5'-monophosphate | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
allocholic acid | | 12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid; allo-bile acid; C24-steroid | human metabolite; marine metabolite; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
beta-ureidoisobutyric acid | | ureidocarboxylic acid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kynurenine | | amino acid zwitterion; kynurenine; non-proteinogenic L-alpha-amino acid | human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nicotinate ribonucleoside | | ammonium betaine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n(6)-(n-threonylcarbonyl)adenosine | | L-threonine derivative; N-(adenosin-N(6)-ylcarbonyl)threonine | Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sedoheptulose 7-phosphate | | ketoheptose phosphate; sedoheptulose derivative | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
histidinol | | amino alcohol; imidazoles | EC 2.3.1.97 (glycylpeptide N-tetradecanoyltransferase) inhibitor; Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiocysteine | | amino acid zwitterion; S-substituted L-cysteine | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nicotinic acid adenine dinucleotide | | nicotinic acid dinucleotide | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4,4-dimethyl-5-alpha-cholesta-(8,24)-dien-3-beta-ol | | 3beta-sterol | human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bradykinin, des-phe(8)-des-arg(9)- | | oligopeptide | human metabolite; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isobutyryl-1-carnitine | | methyl-branched fatty acyl-L-carnitine; O-isobutyrylcarnitine; saturated fatty acyl-L-carnitine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
threitol | | threitol | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
biotin | | biotins; vitamin B7 | coenzyme; cofactor; Escherichia coli metabolite; fundamental metabolite; human metabolite; mouse metabolite; nutraceutical; prosthetic group; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
angiotensin ii | | amino acid zwitterion; angiotensin II | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aceglutamide | | N-acetyl-L-amino acid; N(2)-acetylglutamine; N(2)-acyl-L-glutamine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aflatoxin b1 | | aflatoxin; aromatic ether; aromatic ketone | carcinogenic agent; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isospaglumic acid | | dipeptide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2'-deoxyadenosine triphosphate | | 2'-deoxyadenosine 5'-phosphate; purine 2'-deoxyribonucleoside 5'-diphosphate | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-ethylhydracrylic acid | | branched-chain saturated fatty acid; hydroxy fatty acid; short-chain fatty acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methyl-3-oxovaleric acid | | 3-oxo monocarboxylic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monoacetylcadaverine | | acetamides; N-substituted cadaverine; primary amino compound; secondary carboxamide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
beta-citrylglutamic acid | | N-acyl-L-glutamic acid; tetracarboxylic acid | human metabolite; iron chelator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
maltotriose | | maltotriose trisaccharide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cholestane-3,7,12,26-tetrol | | 12alpha-hydroxy steroid; 26-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
beta-leucine | | beta-amino acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methylbutyrylglycine | | N-acylglycine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
neurotensin (1-8) | | peptide zwitterion; peptide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cholic acid | | 12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid; bile acid; C24-steroid; trihydroxy-5beta-cholanic acid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cortisone | | 11-oxo steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5 alpha-androstane-3 beta,17 beta-diol | | 17beta-hydroxy steroid; 3beta-hydroxy steroid; androstane-3,17-diol | Daphnia magna metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cholesteryl palmitate | | cholesteryl ester | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lanosterol | | 14alpha-methyl steroid; 3beta-sterol; tetracyclic triterpenoid | bacterial metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hydroxyestradiol | | 17beta-hydroxy steroid; 2-hydroxy steroid | carcinogenic agent; human metabolite; metabolite; mouse metabolite; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-hydroxyisourate | | oxopurine | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-formyluracil | | aldehyde; nucleobase analogue; pyrimidone | human metabolite; mutagen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
taurochenodeoxycholic acid | | bile acid taurine conjugate | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5'-methylthioadenosine | | thioadenosine | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5'-deoxyadenosine | | 5'-deoxyribonucleoside; adenosines | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isomaltose | | glycosylglucose | human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glucosamine 6-phosphate | | 2-amino-2-deoxy-D-glucopyranose 6-phosphate | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-hydroxytryptophan | | 5-hydroxytryptophan; amino acid zwitterion; hydroxy-L-tryptophan; non-proteinogenic L-alpha-amino acid | human metabolite; mouse metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dopaquinone | | 1,2-benzoquinones; amino acid zwitterion; L-phenylalanine derivative | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pantetheine | | pantetheines; thiol | human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tryptophanamide | | amino acid amide; tryptophan derivative | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-diphosphomevalonic acid | | carboxyalkyl phosphate | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-dehydrocholesterol | | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; cholestanoid; Delta(5),Delta(7)-sterol | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cysteinylglycine | | dipeptide zwitterion; dipeptide | Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
desmosterol | | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; C27-steroid; cholestanoid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monoiodotyrosine | | amino acid zwitterion; L-tyrosine derivative; monoiodotyrosine; non-proteinogenic L-alpha-amino acid | EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
taurolithocholic acid | | bile acid taurine conjugate; monocarboxylic acid amide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n'-formylkynurenine | | amino acid zwitterion; N-formylkynurenine; non-proteinogenic amino acid derivative; non-proteinogenic L-alpha-amino acid | human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fuculose 1-phosphate | | deoxyaldohexose phosphate | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nicotinamide-beta-riboside | | N-glycosylnicotinamide; pyridine nucleoside | geroprotector; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxyphenylacetaldehyde | | alpha-CH2-containing aldehyde; phenylacetaldehydes | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trimethyllysine | | alpha-amino-acid cation | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
inositol 3,4-bisphosphate | | myo-inositol bisphosphate | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylglucosamine-1-phosphate | | N-acetyl-D-glucosamine 1-phosphate | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
24,25-dihydrolanosterol | | 3beta-sterol; tetracyclic triterpenoid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hydroxyestrone | | 2-hydroxy steroid; catechols | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methoxyestrone | | 17-oxo steroid; 3-hydroxy steroid; alicyclic ketone; aromatic ether; phenolic steroid; phenols | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cortodoxone | | deoxycortisol; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
estradiol-3-glucuronide | | 17beta-hydroxy steroid; beta-D-glucosiduronic acid; steroid glucosiduronic acid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetyl adenylate | | 5'-acylphosphoadenosin | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epiandrosterone | | 17-oxo steroid; 3beta-hydroxy steroid; androstanoid | androgen; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4,4-dimethylcholesta-8,14,24-trienol | | 3beta-sterol; Delta(14) steroid | human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
enkephalin, methionine | | pentapeptide; peptide zwitterion | analgesic; antineoplastic agent; delta-opioid receptor agonist; human metabolite; mu-opioid receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-ketolithocholic acid | | 3alpha-hydroxy steroid; bile acid; monohydroxy-5beta-cholanic acid; oxo-5beta-cholanic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dephosphocoenzyme a | | adenosine 5'-phosphate | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
arachidonic acid | | icosa-5,8,11,14-tetraenoic acid; long-chain fatty acid; omega-6 fatty acid | Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxy-3-methylglutaryl-coenzyme a | | 3-hydroxy-3-methylglutaryl-CoA; 3-hydroxy fatty acyl-CoA | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
retinol | | retinol; vitamin A | human metabolite; mouse metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ribothymidine | | methyluridine | antigen; Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
docosahexaenoate | | docosahexaenoic acid; omega-3 fatty acid | algal metabolite; antineoplastic agent; Daphnia tenebrosa metabolite; human metabolite; mouse metabolite; nutraceutical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tetragastrin | | peptidyl amide; tetrapeptide | anxiogenic; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prostaglandin d2 | | prostaglandins D | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hexanoyl-coenzyme a | | medium-chain fatty acyl-CoA | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
enkephalin, leucine | | pentapeptide; peptide zwitterion | analgesic; delta-opioid receptor agonist; human metabolite; mu-opioid receptor agonist; neurotransmitter; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tyrosine o-sulfate | | aryl sulfate; L-tyrosine derivative; O-sulfoamino acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
retinaldehyde | | retinal; vitamin A | gap junctional intercellular communication inhibitor; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
squalene | | triterpene | human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thyrotropin-releasing hormone | | peptide hormone; tripeptide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-methylproline | | L-alpha-amino acid zwitterion; L-proline derivative; tertiary amino compound | human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
citraconic acid | | dicarboxylic acid; dicarboxylic fatty acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
flavin-adenine dinucleotide | | flavin adenine dinucleotide; vitamin B2 | cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; prosthetic group | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
flavin mononucleotide | | flavin mononucleotide; vitamin B2 | bacterial metabolite; coenzyme; cofactor; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mannose 1-phosphate | | mannose phosphate | fundamental metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycerylphosphorylcholine | | phosphocholines; sn-glycerol 3-phosphates | Escherichia coli metabolite; human metabolite; mouse metabolite; neuroprotective agent; parasympatholytic; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
urocanic acid | | urocanic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cysteine sulfinic acid | | organosulfinic acid; S-substituted L-cysteine | Escherichia coli metabolite; human metabolite; metabotropic glutamate receptor agonist; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cholesterol acetate | | acetate ester; cholesteryl ester | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,6-anhydro-beta-glucopyranose | | anhydrohexose | Arabidopsis thaliana metabolite; biomarker; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycylvaline | | dipeptide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sodium taurodeoxycholate | | bile acid taurine conjugate | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
estrone sulfate | | 17-oxo steroid; steroid sulfate | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydroxylysine | | 5-hydroxylysine; hydroxy-L-lysine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycodeoxycholic acid | | bile acid glycine conjugate | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isobutyryl-coenzyme a | | methyl-branched fatty acyl-CoA; short-chain fatty acyl-CoA | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
galactaric acid | | hexaric acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydroxycoprostane | | 3alpha-hydroxy steroid; 7alpha-hydroxy steroid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
angiotensin i, ile(5)- | | angiotensin; peptide zwitterion | human metabolite; neurotransmitter agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fructosyl-glycine | | fructosamine; glycine derivative; glyco-amino acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
arachidoyl-coenzyme a | | 11,12-saturated fatty acyl-CoA; long-chain fatty acyl-CoA | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lignoceroyl-coenzyme a | | very long-chain fatty acyl-CoA | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-hydroxybenzimidazole | | benzimidazoles; phenols | bacterial metabolite; human metabolite; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-carbamylglutamate | | glutamic acid derivative; ureas | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
citramalate | | dicarboxylic acid dianion | human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-cresol sulfate | | aryl sulfate | gut flora metabolite; human metabolite; uremic toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sphingosine | | sphing-4-enine | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dinoprostone | | prostaglandins E | human metabolite; mouse metabolite; oxytocic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dinoprost | | monocarboxylic acid; prostaglandins Falpha | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leukotriene a4 | | epoxy fatty acid; leukotriene; long-chain fatty acid; oxylipin; polyunsaturated fatty acid | human metabolite; mouse metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prostaglandin b1 | | prostaglandins B | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
calcitriol | | D3 vitamins; hydroxycalciol; triol | antineoplastic agent; antipsoriatic; bone density conservation agent; calcium channel agonist; calcium channel modulator; hormone; human metabolite; immunomodulator; metabolite; mouse metabolite; nutraceutical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
psychosine | | glycosylsphingoid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
11-cis-retinal | | retinal | chromophore; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leukotriene b4 | | dihydroxy monocarboxylic acid; hydroxy polyunsaturated fatty acid; leukotriene; long-chain fatty acid | human metabolite; mouse metabolite; plant metabolite; vasoconstrictor agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leukotriene c4 | | leukotriene | bronchoconstrictor agent; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prostaglandin f2beta | | prostaglandins Fbeta | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8,11,14-eicosatrienoic acid | | fatty acid 20:3; long-chain fatty acid | fungal metabolite; human metabolite; nutraceutical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
15-keto-5,8,11,13-eicosatetraenoic acid | | oxoicosatetraenoic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alprostadil | | prostaglandins E | anticoagulant; human metabolite; platelet aggregation inhibitor; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
15-hydroxy-5,8,11,13-eicosatetraenoic acid | | (5Z,8Z,11Z,13E)-15-HETE | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-hydroxy-6,8,11,14-eicosatetraenoic acid | | HETE | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cholecalciferol | | D3 vitamins; hydroxy seco-steroid; seco-cholestane; secondary alcohol; steroid hormone | geroprotector; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leukotriene d4 | | dipeptide; leukotriene; organic sulfide | bronchoconstrictor agent; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prostaglandin a2 | | prostaglandins A | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prostaglandin b2 | | prostaglandins B | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prostaglandin g2 | | prostaglandins G | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
9-deoxy-delta-9-prostaglandin d2 | | prostaglandins J | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-ketoprostaglandin f1 alpha | | prostaglandins Falpha | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
11-dehydro-thromboxane b2 | | thromboxane | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lipoxin a4 | | hydroxy polyunsaturated fatty acid; lipoxin; long-chain fatty acid | human metabolite; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-linolenic acid | | linolenic acid; omega-6 fatty acid | human metabolite; mouse metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prostaglandin e3 | | prostaglandins E | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leukotriene f-4 | | dipeptide; leukotriene; organic sulfide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prostaglandin f1 | | prostaglandins Falpha | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
previtamin d(3) | | D3 vitamins; hydroxy seco-steroid; seco-cholestane; secondary alcohol | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
brassicasterol | | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; ergostanoid; phytosterols | algal metabolite; animal metabolite; biomarker; EC 1.3.1.72 (Delta(24)-sterol reductase) inhibitor; human metabolite; marine metabolite; plant metabolite; sterol biosynthesis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
retinoyl beta-glucuronide | | glucuronic acids; retinoid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prostaglandin d3 | | prostaglandins D | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glyceryl 2-arachidonate | | 2-acylglycerol 20:4; endocannabinoid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tocotrienol, alpha | | tocotrienol; vitamin E | ferroptosis inhibitor; human metabolite; neuroprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
11-ketotestosterone | | 11-oxo steroid; 17beta-hydroxy steroid; 3-oxo-Delta(4) steroid; androstanoid | androgen; human metabolite; marine xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phthioic acid | | branched-chain saturated fatty acid; fatty acid 26:0; methyl-branched fatty acid; very long-chain fatty acid | Aspergillus metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-decenoic acid | | 2-decenoic acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
9,11-linoleic acid | | octadeca-9,11-dienoic acid | anti-inflammatory agent; antiatherogenic agent; antineoplastic agent; apoptosis inducer; bacterial xenobiotic metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
9-hydroxy-10,12-octadecadienoic acid | | HODE; octadecadienoic acid | human metabolite; metabolite; mouse metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
17-phenyltrinorprostaglandin e2 | | alicyclic ketone; beta-hydroxy ketone; hydroxy monocarboxylic acid; olefinic compound; oxo monocarboxylic acid; prostanoid; secondary alcohol | human metabolite; prostaglandin receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thromboxane b2 | | thromboxanes B | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thromboxane b3 | | thromboxanes B | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
12-hydroxy-5,8,10,14-eicosatetraenoic acid | | (5Z,8Z,10E,14Z)-12-hydroxyicosatetraenoic acid; HETE | human metabolite; pro-angiogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
20-hydroxy-5,8,11,14-eicosatetraenoic acid | | HETE; hydroxy monocarboxylic acid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-oxo-6,8,11,14-eicosatetraenoic acid | | oxoicosatetraenoic acid | human metabolite; immunomodulator; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-isoprostaglandin e2 | | cyclic ketone; diol; prostanoid; secondary alcohol | bronchoconstrictor agent; human metabolite; rat metabolite; vasoconstrictor agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oleylamide | | primary fatty amide | human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monolinolein | | 1-acylglycerol 18:2; rac-1-monoacylglycerol | antiviral agent; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,25-dihydroxy-24-oxo-vitamin d3 | | hydroxycalciol; oxocalciol; tertiary alpha-hydroxy ketone | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
calcifediol | | D3 vitamins; diol; hydroxycalciol | bone density conservation agent; human metabolite; metabolite; mouse metabolite; nutraceutical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hyodeoxycholic acid | | 5beta-cholanic acids; 6alpha,20xi-murideoxycholic acid; bile acid; C24-steroid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vitamin k 1 | | phylloquinones; vitamin K | cofactor; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cerium | | CE(18:2); cholesteryl octadeca-9,12-dienoate | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xylulose | | xylulose | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
11-dehydrocorticosterone | | 11-oxo steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; corticosteroid; primary alpha-hydroxy ketone | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-butyl oleate | | fatty acid ester | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-hydroxyadenine | | 6-aminopurines; heteroaryl hydroxy compound; nucleobase analogue; oxopurine | bacterial metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
erucyl amide | | 13-docosenamide | EC 3.1.1.7 (acetylcholinesterase) inhibitor; human metabolite; mammalian metabolite; plant metabolite; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vitamin mk 8 | | menaquinone | Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,3-oxidosqualene | | 2,3-epoxysqualene | human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-keto-4-hydroxyglutarate | | oxo dicarboxylate | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deoxyribose | | deoxypentose | human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
iditol | | iditol | fungal metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glutamate | | glutamate(1-); polar amino acid zwitterion | EC 6.3.1.2 (glutamate--ammonia ligase) inhibitor; human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fumarates | | butenedioate; C4-dicarboxylate | human metabolite; metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cerotate | | fatty acid anion 26:0; omega-methyl fatty acid anion; very long-chain fatty acid anion | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
adenosine triphosphate | | nucleoside 5'-triphoshate(4-) | cofactor; fundamental metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
docosapentaenoic acid | | docosapentaenoic acid; omega-3 fatty acid | algal metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methylbutyrylcarnitine | | C5-acylcarnitine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hexanoylcarnitine | | hexanoate ester; O-acylcarnitine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
linoleamide | | primary fatty amide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
13-cis-retinal | | retinal | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxyretinoic acid | | retinoid; secondary allylic alcohol | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-oxo-2-nonenal | | enal; enone | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
20,22-dihydroxycholesterol | | 20-hydroxy steroid; 22-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; cholestanoid; oxysterol | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
biotinate | | monocarboxylic acid anion; vitamin B7 | cofactor; human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6 beta-hydroxycortisol | | 11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; 6beta-hydroxy steroid; C21-steroid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | human metabolite; mammalian metabolite; probe | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fuculose | | deoxyketohexose | Escherichia coli metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-glutamylvaline | | glutamyl-L-amino acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ophthalmic acid | | L-glutamine derivative | biomarker; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetylcarnitine | | O-acetylcarnitine; saturated fatty acyl-L-carnitine | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
adenosine diphosphate | | nucleoside 5'-diphosphate(3-) | fundamental metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyclic amp | | organophosphate oxoanion | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,23,25-trihydroxyvitamin d3 | | D3 vitamins; hydroxy seco-steroid; hydroxycalciol; tetrol | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phosphocreatine | | phosphagen; phosphoamino acid | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ursodoxicoltaurine | | bile acid taurine conjugate | anti-inflammatory agent; apoptosis inhibitor; bone density conservation agent; cardioprotective agent; human metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
homocarnosine | | dipeptide zwitterion; dipeptide; homocarnosine; L-histidine derivative; N-acyl-L-alpha-amino acid anion; N-acyl-L-alpha-amino acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxyproline | | 3-hydroxyproline; amino acid zwitterion; D-proline derivative | bacterial metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cytidine diphosphate choline | | nucleotide-(amino alcohol)s; phosphocholines | human metabolite; mouse metabolite; neuroprotective agent; psychotropic drug; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
octanoylcarnitine | | O-octanoylcarnitine; saturated fatty acyl-L-carnitine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
palmitoylcarnitine | | O-palmitoylcarnitine; saturated fatty acyl-L-carnitine | EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyclic 3',5'-thymidine monophosphate | | 3',5'-cyclic pyrimidine nucleotide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pristanal | | 2-methyl-branched fatty aldehyde; saturated fatty aldehyde | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lanosten-3-ol-32-al | | 14alpha-formyl steroid; 3beta-sterol; tetracyclic triterpenoid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiamine pyrophosphate | | organophosphate oxoanion; vitamin B1 | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
adenosine monophosphate | | nucleoside 5'-monophosphate(2-) | cofactor; fundamental metabolite; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nad | | organophosphate oxoanion | cofactor; human metabolite; hydrogen acceptor; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cob(ii)alamin | | cobalamin | cofactor; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nociceptin | | organic molecular entity; polypeptide | human metabolite; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxy-3-methyl-hexanoic acid | | 3-hydroxy monocarboxylic acid; volatile organic compound | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
uridine diphosphate | | nucleoside 5'-diphosphate(3-) | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylgalactosamine-1-phosphate | | D-galactosamine 1-phosphate | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-phospho-5-s-methylthioribulose | | organophosphate oxoanion | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s-adenosylmethionine | | organic cation; sulfonium compound | coenzyme; cofactor; human metabolite; micronutrient; Mycoplasma genitalium metabolite; nutraceutical; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
10-nitro-oleic acid | | long-chain fatty acid; monounsaturated fatty acid; nitro fatty acid | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ticrynafen | | monocarboxylic acid anion; organophosphate oxoanion | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s-(1,2-dicarboxyethyl)cysteine | | L-cysteine thioether; tricarboxylic acid | human metabolite; Maillard reaction product | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
neurotensin | | peptide hormone | human metabolite; mitogen; neurotransmitter; vulnerary | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
apelin-13 peptide | | oligopeptide | antihypertensive agent; autophagy inhibitor; biomarker; human metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
p-Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | | polypeptide | apoptosis inhibitor; human metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
taurolithocholic acid 3-sulfate | | steroid sulfate oxoanion | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
inositol 1,3,4-trisphosphate | | inositol phosphate oxoanion | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diadenosine tetraphosphate | | organophosphate oxoanion | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-ketoarginine | | 2-oxo monocarboxylic acid; zwitterion | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
adenosine diphosphate glucose | | NDP-alpha-D-glucose(2-); ribonucleoside 5'-diphosphate-alpha-D-glucose(2-) | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nicotinate mononucleotide | | organophosphate oxoanion | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oleoylcarnitine | | monounsaturated fatty acyl-L-carnitine | glycine transporter 2 inhibitor; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
uridine diphosphate n-acetylgalactosamine | | nucleotide-sugar oxoanion | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-phosphogluconolactone | | organophosphate oxoanion | human metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxyisovalerylcarnitine | | O-acylcarnitine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
angiotensin i | | angiotensin; peptide zwitterion | antihypertensive agent; cardioprotective agent; human metabolite; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
9-PAHSA | | FAHFA; long-chain fatty acid | anti-inflammatory agent; human metabolite; hypoglycemic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
angiotensin i | | angiotensin; peptide zwitterion | human metabolite; neurotransmitter agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lugdunin | | homodetic cyclic peptide; indoles; macrocycle; peptide antibiotic; thiazolidines | human metabolite; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyclic gmp | | 3',5'-cyclic purine nucleotide; guanyl ribonucleotide | Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deoxyguanosine | | purine 2'-deoxyribonucleoside; purines 2'-deoxy-D-ribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deoxyinosine | | purine 2'-deoxyribonucleoside; purines 2'-deoxy-D-ribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deoxyguanosine triphosphate | | deoxyguanosine phosphate; guanyl deoxyribonucleotide; purine 2'-deoxyribonucleoside 5'-triphosphate | Arabidopsis thaliana metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7,8-dihydroneopterin | | dihydropterin; neopterins | Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deoxyinosine monophosphate | | deoxyinosine phosphate; purine 2'-deoxyribonucleoside 5'-monophosphate | Escherichia coli metabolite; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
guanosine diphosphate mannose | | GDP-D-mannose | Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
guanine | | 2-aminopurines; oxopurine; purine nucleobase | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
inosinic acid | | inosine phosphate; purine ribonucleoside 5'-monophosphate | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
inosine | | inosines; purines D-ribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
inosine triphosphate | | inosine phosphate; purine ribonucleoside 5'-triphosphate | Escherichia coli metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sapropterin | | 5,6,7,8-tetrahydrobiopterin | coenzyme; cofactor; diagnostic agent; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
folic acid | | folic acids; N-acyl-amino acid | human metabolite; mouse metabolite; nutrient | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dyspropterin | | biopterins; tetrahydropterin | human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-nitroguanosine 3',5'-cyclic monophosphate | | 3',5'-cyclic purine nucleotide; C-nitro compound | biomarker; Brassica napus metabolite; human metabolite; signalling molecule | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n(2),n(2)-dimethylguanosine | | methylguanosine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
creatinine | | imidazolidinone; lactam | diagnostic agent; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
apelin-12 peptide | | oligopeptide | biomarker; human blood serum metabolite; human metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone | | 1,4-benzoquinones | cofactor | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
embelin | | dihydroxy-1,4-benzoquinones | antimicrobial agent; antineoplastic agent; hepatitis C protease inhibitor; plant metabolite | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
idebenone | | 1,4-benzoquinones; primary alcohol | antioxidant; ferroptosis inhibitor | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
ubiquinone q1 | | ubiquinones | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
quinone | | 1,4-benzoquinones | cofactor; human xenobiotic metabolite; mouse metabolite | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
2,5-dimethyl-4-benzoquinone | | | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
thymoquinone | | 1,4-benzoquinones | adjuvant; anti-inflammatory agent; antidepressant; antineoplastic agent; antioxidant; cardioprotective agent; plant metabolite | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
2-methyl-1,4-benzoquinone | | | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
2-tert-butyl-4-quinone | | | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
2,6-dimethoxy-1,4-benzoquinone | | | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
ubiquinone-o | | ubiquinones | Escherichia coli metabolite; human metabolite | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
primin | | 1,4-benzoquinones | allergen; antifeedant; antimicrobial agent; hapten; metabolite | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
rapanone | | dihydroxy-1,4-benzoquinones | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
ubiquinone q2 | | ubiquinones | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
coenzyme q10 | | ubiquinones | antioxidant; ferroptosis inhibitor; human metabolite | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
ubiquinone 6 | | ubiquinones | Saccharomyces cerevisiae metabolite | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
4-hydroxybenzoic acid | | monohydroxybenzoic acid | algal metabolite; plant metabolite | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
acetic acid | | monocarboxylic acid | antimicrobial food preservative; Daphnia magna metabolite; food acidity regulator; protic solvent | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
formic acid | | monocarboxylic acid | antibacterial agent; astringent; metabolite; protic solvent; solvent | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
methane | | alkane; gas molecular entity; mononuclear parent hydride; one-carbon compound | bacterial metabolite; fossil fuel; greenhouse gas | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
choline | | cholines | allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter; nutrient; plant metabolite; Saccharomyces cerevisiae metabolite | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
salicylic acid | | monohydroxybenzoic acid | algal metabolite; antifungal agent; antiinfective agent; EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor; keratolytic drug; plant hormone; plant metabolite | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
3-hydroxybutyric acid | | (omega-1)-hydroxy fatty acid; 3-hydroxy monocarboxylic acid; hydroxybutyric acid | human metabolite | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
malic acid | | 2-hydroxydicarboxylic acid; C4-dicarboxylic acid | food acidity regulator; fundamental metabolite | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
dihydroxyphenylalanine | | hydroxyphenylalanine; non-proteinogenic alpha-amino acid; tyrosine derivative | human metabolite | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
inositol | | cyclitol; hexol | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
melatonin | | acetamides; tryptamines | anticonvulsant; central nervous system depressant; geroprotector; hormone; human metabolite; immunological adjuvant; mouse metabolite; radical scavenger | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
putrescine | | alkane-alpha,omega-diamine | antioxidant; fundamental metabolite | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
pyruvic acid | | 2-oxo monocarboxylic acid | cofactor; fundamental metabolite | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
spermidine | | polyazaalkane; triamine | autophagy inducer; fundamental metabolite; geroprotector | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
succinic acid | | alpha,omega-dicarboxylic acid; C4-dicarboxylic acid | anti-ulcer drug; fundamental metabolite; micronutrient; nutraceutical; radiation protective agent | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
uric acid | | uric acid | Escherichia coli metabolite; human metabolite; mouse metabolite | 1994 | 2003 | 25.5 | low | 0 | 0 | 1 | 1 | 0 | 0 |
isopentenyl pyrophosphate | | prenol phosphate | antigen; antioxidant; epitope; Escherichia coli metabolite; mouse metabolite; phosphoantigen | 2006 | 2014 | 14.0 | low | 0 | 0 | 0 | 1 | 1 | 0 |
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | | methylpyridines; phenylpyridine; tetrahydropyridine | neurotoxin | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
beta-resorcylic acid | | | | 2015 | 2019 | 7.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
2,2'-azobis(2-amidinopropane) | | monoazo compound | | 1992 | 1992 | 32.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
acetaminophen | | acetamides; phenols | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; cyclooxygenase 3 inhibitor; environmental contaminant; ferroptosis inducer; geroprotector; hepatotoxic agent; human blood serum metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
acetazolamide | | monocarboxylic acid amide; sulfonamide; thiadiazoles | anticonvulsant; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
etidronate | | 1,1-bis(phosphonic acid) | antineoplastic agent; bone density conservation agent; chelator | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
carbonyl cyanide p-trifluoromethoxyphenylhydrazone | | aromatic ether; hydrazone; nitrile; organofluorine compound | ATP synthase inhibitor; geroprotector; ionophore | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
idebenone | | 1,4-benzoquinones; primary alcohol | antioxidant; ferroptosis inhibitor | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
2-propanol | | secondary alcohol; secondary fatty alcohol | protic solvent | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
ubiquinone q1 | | ubiquinones | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
risedronic acid | | pyridines | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
pirinixic acid | | aryl sulfide; organochlorine compound; pyrimidines | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
reserpine | | alkaloid ester; methyl ester; yohimban alkaloid | adrenergic uptake inhibitor; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; first generation antipsychotic; plant metabolite; xenobiotic | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
thyroxine | | 2-halophenol; iodophenol; L-phenylalanine derivative; non-proteinogenic L-alpha-amino acid; thyroxine zwitterion; thyroxine | antithyroid drug; human metabolite; mouse metabolite; thyroid hormone | 1984 | 1995 | 34.5 | low | 0 | 1 | 1 | 0 | 0 | 0 |
2-acetylaminofluorene | | 2-acetamidofluorenes | antimitotic; carcinogenic agent; epitope; mutagen | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
triiodothyronine | | 2-halophenol; amino acid zwitterion; iodophenol; iodothyronine | human metabolite; mouse metabolite; thyroid hormone | 1984 | 2003 | 27.7 | low | 0 | 1 | 0 | 2 | 0 | 0 |
diethylnitrosamine | | nitrosamine | carcinogenic agent; hepatotoxic agent; mutagen | 1999 | 1999 | 25.0 | low | 0 | 0 | 2 | 0 | 0 | 0 |
carbon tetrachloride | | chlorocarbon; chloromethanes | hepatotoxic agent; refrigerant | 1986 | 2007 | 25.4 | low | 0 | 1 | 2 | 2 | 0 | 0 |
aspartic acid | | aspartate family amino acid; aspartic acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; mouse metabolite; neurotransmitter | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
glutamine | | amino acid zwitterion; glutamine family amino acid; glutamine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid | EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
adenosine diphosphate | | adenosine 5'-phosphate; purine ribonucleoside 5'-diphosphate | fundamental metabolite; human metabolite | 2004 | 2013 | 14.0 | low | 0 | 0 | 0 | 1 | 2 | 0 |
uridine | | uridines | drug metabolite; fundamental metabolite; human metabolite | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
galactose | | D-galactose; galactopyranose | Escherichia coli metabolite; mouse metabolite | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
edetic acid | | ethylenediamine derivative; polyamino carboxylic acid; tetracarboxylic acid | anticoagulant; antidote; chelator; copper chelator; geroprotector | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
tyrosine | | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; proteinogenic amino acid; tyrosine | EC 1.3.1.43 (arogenate dehydrogenase) inhibitor; fundamental metabolite; micronutrient; nutraceutical | 1965 | 1984 | 49.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
methionine | | aspartate family amino acid; L-alpha-amino acid; methionine zwitterion; methionine; proteinogenic amino acid | antidote to paracetamol poisoning; human metabolite; micronutrient; mouse metabolite; nutraceutical | 1984 | 2016 | 19.7 | low | 0 | 1 | 0 | 0 | 2 | 0 |
phenylalanine | | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; phenylalanine; proteinogenic amino acid | algal metabolite; EC 3.1.3.1 (alkaline phosphatase) inhibitor; Escherichia coli metabolite; human xenobiotic metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite | 1965 | 1965 | 59.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
methylamine | | methylamines; one-carbon compound; primary aliphatic amine | mouse metabolite | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
acetonitrile | | aliphatic nitrile; volatile organic compound | EC 3.5.1.4 (amidase) inhibitor; NMR chemical shift reference compound; polar aprotic solvent | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
tert-butylhydroperoxide | | alkyl hydroperoxide | antibacterial agent; oxidising agent | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
rotenone | | organic heteropentacyclic compound; rotenones | antineoplastic agent; metabolite; mitochondrial NADH:ubiquinone reductase inhibitor; phytogenic insecticide; piscicide; toxin | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
propylparaben | | benzoate ester; paraben; phenols | antifungal agent; antimicrobial agent | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
methyl acrylate | | enoate ester | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
pyrroles | | pyrrole; secondary amine | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
malondialdehyde | | dialdehyde | biomarker | 1991 | 2010 | 22.8 | low | 0 | 0 | 3 | 3 | 0 | 0 |
acetylcysteine | | acetylcysteine; L-cysteine derivative; N-acetyl-L-amino acid | antidote to paracetamol poisoning; antiinfective agent; antioxidant; antiviral drug; ferroptosis inhibitor; geroprotector; human metabolite; mucolytic; radical scavenger; vulnerary | 2004 | 2008 | 18.0 | low | 0 | 0 | 0 | 2 | 0 | 0 |
dehydroepiandrosterone sulfate | | 17-oxo steroid; steroid sulfate | EC 2.7.1.33 (pantothenate kinase) inhibitor; human metabolite; mouse metabolite | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
deoxycytidine | | pyrimidine 2'-deoxyribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
ammonium hydroxide | | inorganic hydroxy compound | food acidity regulator | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
d-alpha tocopherol | | alpha-tocopherol | algal metabolite; antiatherogenic agent; anticoagulant; antioxidant; antiviral agent; EC 2.7.11.13 (protein kinase C) inhibitor; immunomodulator; micronutrient; nutraceutical; plant metabolite | 1984 | 2015 | 22.6 | low | 0 | 1 | 13 | 17 | 3 | 0 |
tocopherols | | | | 2001 | 2005 | 21.0 | low | 0 | 0 | 0 | 2 | 0 | 0 |
tetrachloroisophthalonitrile | | aromatic fungicide; dinitrile; tetrachlorobenzene | antifungal agrochemical | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
stavudine | | dihydrofuran; nucleoside analogue; organic molecular entity | antimetabolite; antiviral agent; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
mercury | | elemental mercury; zinc group element atom | neurotoxin | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
titanium | | titanium group element atom | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
cadmium | | cadmium molecular entity; zinc group element atom | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
zalcitabine | | pyrimidine 2',3'-dideoxyribonucleoside | antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
copper sulfate | | metal sulfate | emetic; fertilizer; sensitiser | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
menoctone | | | | 1981 | 1981 | 43.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
phenyl acetate | | benzenes; phenyl acetates | | 1965 | 2008 | 37.5 | low | 0 | 1 | 0 | 1 | 0 | 0 |
glutamic acid | | glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
alovudine | | pyrimidine 2',3'-dideoxyribonucleoside | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
zidovudine | | azide; pyrimidine 2',3'-dideoxyribonucleoside | antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
1-methyl-4-phenylpyridinium | | pyridinium ion | apoptosis inducer; herbicide; human xenobiotic metabolite; neurotoxin | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
ng-nitroarginine methyl ester | | alpha-amino acid ester; L-arginine derivative; methyl ester; N-nitro compound | EC 1.14.13.39 (nitric oxide synthase) inhibitor | 2004 | 2008 | 17.7 | low | 0 | 0 | 0 | 3 | 0 | 0 |
lovastatin | | delta-lactone; fatty acid ester; hexahydronaphthalenes; polyketide; statin (naturally occurring) | anticholesteremic drug; antineoplastic agent; Aspergillus metabolite; prodrug | 1984 | 2014 | 24.6 | low | 0 | 1 | 2 | 1 | 1 | 0 |
simvastatin | | delta-lactone; fatty acid ester; hexahydronaphthalenes; statin (semi-synthetic) | EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor; EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor; ferroptosis inducer; geroprotector; prodrug | 2004 | 2017 | 13.2 | low | 1 | 0 | 0 | 2 | 2 | 0 |
pravastatin | | 3-hydroxy carboxylic acid; carbobicyclic compound; carboxylic ester; hydroxy monocarboxylic acid; secondary alcohol; statin (semi-synthetic) | anticholesteremic drug; environmental contaminant; metabolite; xenobiotic | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
adenosine | | adenosines; purines D-ribonucleoside | analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
n-acetylaspartic acid | | N-acetyl-L-amino acid; N-acyl-L-aspartic acid | antioxidant; human metabolite; mouse metabolite; nutraceutical; rat metabolite | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
glutathione disulfide | | glutathione derivative; organic disulfide | Escherichia coli metabolite; mouse metabolite | 1994 | 2001 | 26.5 | low | 0 | 0 | 1 | 1 | 0 | 0 |
dicarbine | | | | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
gamma-tocopherol | | tocopherol; vitamin E | algal metabolite; food antioxidant; plant metabolite | 2001 | 2010 | 18.0 | low | 0 | 0 | 0 | 3 | 0 | 0 |
cobalt | | cobalt group element atom; metal allergen | micronutrient | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
methotrexate | | dicarboxylic acid; monocarboxylic acid amide; pteridines | abortifacient; antimetabolite; antineoplastic agent; antirheumatic drug; dermatologic drug; DNA synthesis inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; immunosuppressive agent | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
xylose | | D-xylose | | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
duroquinol | | hydroquinones; methylbenzene | bacterial xenobiotic metabolite; volatile oil component | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
ezetimibe | | azetidines; beta-lactam; organofluorine compound | anticholesteremic drug; antilipemic drug; antimetabolite | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
1-methyl-4-phenyl-2,3-dihydropyridinium | | | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
isospaglumic acid | | dipeptide | human metabolite | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
blastmycin | | amidobenzoic acid | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
mevalonic acid | | 3,5-dihydroxy-3-methylpentanoic acid | | 1984 | 2014 | 25.0 | low | 0 | 1 | 0 | 0 | 1 | 0 |
dehydroascorbic acid | | dehydroascorbic acid; vitamin C | coenzyme; mouse metabolite | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
metrizamide | | amino sugar | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
resveratrol | | resveratrol | antioxidant; phytoalexin; plant metabolite; quorum sensing inhibitor; radical scavenger | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
retinol | | retinol; vitamin A | human metabolite; mouse metabolite; plant metabolite | 1994 | 2007 | 21.2 | low | 0 | 0 | 1 | 3 | 0 | 0 |
farnesyl pyrophosphate | | farnesyl diphosphate | Escherichia coli metabolite; mouse metabolite | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
geranyl pyrophosphate | | polyprenyl diphosphate | Escherichia coli metabolite; mouse metabolite | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
lycopene | | acyclic carotene | antioxidant; plant metabolite | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
geranylgeranyl pyrophosphate | | geranylgeranyl diphosphate | mouse metabolite | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
5-fluoro-2'-deoxycytidine | | | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
ammonium acetate | | acetate salt; ammonium salt | buffer; food acidity regulator | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
squalene | | triterpene | human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
pyrophosphate | | diphosphate ion | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
sesquiterpenes | | | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
methimazole | | 1,3-dihydroimidazole-2-thiones | antithyroid drug | 1995 | 2003 | 25.0 | low | 0 | 0 | 1 | 1 | 0 | 0 |
D-fructopyranose | | cyclic hemiketal; D-fructose; fructopyranose | sweetening agent | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
nadp | | | | 1999 | 2004 | 22.5 | low | 0 | 0 | 1 | 1 | 0 | 0 |
cobaltous chloride | | cobalt salt; inorganic chloride | allergen; calcium channel blocker; sensitiser; two-colour indicator | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
24,25-epoxycholesterol | | 3beta-hydroxy-Delta(5)-steroid; cholestanoid; epoxy steroid | liver X receptor agonist | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
naphthoquinones | | | | 1981 | 1981 | 43.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
ubiquinone q2 | | ubiquinones | | 1986 | 2017 | 20.2 | low | 0 | 1 | 5 | 2 | 6 | 0 |
dinoprost | | monocarboxylic acid; prostaglandins Falpha | human metabolite; mouse metabolite | 2006 | 2010 | 16.0 | low | 0 | 0 | 0 | 2 | 0 | 0 |
vitamin k semiquinone radical | | | | 1981 | 1981 | 43.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
retinol palmitate | | all-trans-retinyl ester; retinyl palmitate | antioxidant; Escherichia coli metabolite; human xenobiotic metabolite | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
solanesyl pyrophosphate | | all-trans-polyprenyl diphosphate; nonaprenyl diphosphate | | 1997 | 2006 | 22.5 | high | 0 | 0 | 1 | 1 | 0 | 0 |
(all-e) phytoene | | phytoene | plant metabolite | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
coenzyme q10 | | ubiquinones | antioxidant; ferroptosis inhibitor; human metabolite | 1981 | 2021 | 20.4 | medium | 0 | 6 | 13 | 34 | 12 | 1 |
8-epi-prostaglandin f2alpha | | F2-isoprostane | biomarker; bronchoconstrictor agent; vasoconstrictor agent | 2006 | 2010 | 16.0 | low | 0 | 0 | 0 | 2 | 0 | 0 |
ubiquinone 8 | | ubiquinones | biomarker | 1981 | 2016 | 20.3 | low | 0 | 2 | 0 | 5 | 4 | 0 |
sirolimus | | antibiotic antifungal drug; cyclic acetal; cyclic ketone; ether; macrolide lactam; organic heterotricyclic compound; secondary alcohol | antibacterial drug; anticoronaviral agent; antineoplastic agent; bacterial metabolite; geroprotector; immunosuppressive agent; mTOR inhibitor | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
ubiquinone 7 | | ubiquinones | | 1981 | 2022 | 24.8 | low | 0 | 2 | 0 | 0 | 1 | 1 |
lead | | carbon group element atom; elemental lead; metal atom | neurotoxin | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
plastoquinone | | plastoquinone | | 1995 | 2012 | 20.3 | low | 0 | 0 | 1 | 1 | 1 | 0 |
puerarin | | C-glycosyl compound; isoflavonoid | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
2,3-oxidosqualene | | 2,3-epoxysqualene | human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
cysteine | | cysteinium | fundamental metabolite | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
selenium | | chalcogen; nonmetal atom | micronutrient | 1994 | 1999 | 28.3 | low | 0 | 0 | 3 | 0 | 0 | 0 |
dizocilpine maleate | | maleate salt; tetracyclic antidepressant | anaesthetic; anticonvulsant; neuroprotective agent; nicotinic antagonist; NMDA receptor antagonist | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
antimycin a | | amidobenzoic acid | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
dolichols | | polyterpene | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
squalestatin 1 | | acetate ester; cyclic ketal; oxabicycloalkane; polyketide; tertiary alcohol; tricarboxylic acid | EC 2.5.1.21 (squalene synthase) inhibitor; fungal metabolite | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
ubiquinone q3 | | | | 2011 | 2012 | 12.5 | medium | 0 | 0 | 0 | 0 | 2 | 0 |
2,3,22,23-dioxidosqualene | | | | 2014 | 2014 | 10.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
rhodoquinone | | | | 1985 | 2004 | 29.5 | low | 0 | 1 | 0 | 1 | 0 | 0 |
5-demethoxyubiquinone-9 | | prenylquinone | | 2004 | 2019 | 12.5 | high | 0 | 0 | 0 | 1 | 1 | 0 |
s-allylmercaptocysteine | | | | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
n(6)-cyclohexyladenosine | | | | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
u 18666a | | hydrochloride | antiviral agent; EC 1.3.1.72 (Delta(24)-sterol reductase) inhibitor; Hedgehog signaling pathway inhibitor; nicotinic antagonist; sterol biosynthesis inhibitor | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
ubiquinol | | polyprenylhydroquinone; ubiquinol | biomarker; metabolite | 1994 | 2016 | 20.6 | low | 0 | 0 | 3 | 0 | 2 | 0 |
tetrahydrouridine | | | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
aflatoxin m1 | | aflatoxin; aromatic ether; aromatic ketone; tertiary alcohol | Aspergillus metabolite; human xenobiotic metabolite; mammalian metabolite | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
nad | | organophosphate oxoanion | cofactor; human metabolite; hydrogen acceptor; Saccharomyces cerevisiae metabolite | 1999 | 2006 | 20.5 | low | 0 | 0 | 1 | 3 | 0 | 0 |
glycoprotein e2, hepatitis c virus | | | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
phosphatidylcholines | | 1,2-diacyl-sn-glycero-3-phosphocholine | | 1994 | 2013 | 20.5 | low | 0 | 0 | 1 | 0 | 1 | 0 |
ubiquinone | | | | 1959 | 2022 | 17.9 | high | 2 | 18 | 39 | 72 | 91 | 6 |
hydroxyoctadecadienoic acid | | | | 2006 | 2010 | 16.0 | low | 0 | 0 | 0 | 2 | 0 | 0 |
ascorbic acid | | ascorbic acid; vitamin C | coenzyme; cofactor; flour treatment agent; food antioxidant; food colour retention agent; geroprotector; plant metabolite; skin lightening agent | 1994 | 2015 | 19.3 | low | 0 | 0 | 2 | 3 | 2 | 0 |
transforming growth factor beta | | | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
oligomycins | | | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
praliciguat | | aminopyrimidine; isoxazoles; monofluorobenzenes; organofluorine compound; pyrazoles; secondary amino compound; tertiary alcohol | anti-inflammatory agent; antihypertensive agent; soluble guanylate cyclase activator; vasodilator agent | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
cyclosporine | | | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
deoxyguanosine | | purine 2'-deoxyribonucleoside; purines 2'-deoxy-D-ribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 1994 | 2006 | 24.0 | low | 0 | 0 | 1 | 1 | 0 | 0 |
didanosine | | purine 2',3'-dideoxyribonucleoside | antimetabolite; antiviral drug; EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor; geroprotector; HIV-1 reverse transcriptase inhibitor | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
8-hydroxy-2'-deoxyguanosine | | guanosines | biomarker | 1994 | 2006 | 24.0 | low | 0 | 0 | 1 | 1 | 0 | 0 |
prodigiosin | | | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
5-methyltetrahydrofolate | | | | 1981 | 1981 | 43.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
cycloprodigiosin | | | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
Acidosis, Lactic | 0 | | 2016 | 2018 | 7.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
Acoustic Trauma | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Acute Hepatic Failure | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Acute Liver Injury, Drug-Induced | 0 | | 1997 | 1998 | 26.5 | low | 0 | 0 | 2 | 0 | 0 | 0 |
Adjuvant Arthritis | 0 | | 2010 | 2021 | 8.5 | low | 0 | 0 | 0 | 1 | 0 | 1 |
Aging | 0 | | 1992 | 2013 | 20.9 | low | 0 | 0 | 4 | 9 | 1 | 0 |
Aging, Premature | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Akinetic-Rigid Variant of Huntington Disease | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Albuminuria | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Alcoholic Liver Diseases | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Alloxan Diabetes | 0 | | 2000 | 2014 | 17.0 | low | 0 | 0 | 1 | 4 | 1 | 0 |
Amentia | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Amyloidosis | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Anemia, Sickle Cell | 0 | | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Anemia, Splenic | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Arrhythmia | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Arrhythmias, Cardiac | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Arthritis, Rheumatoid | 0 | | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
Ascites | 0 | | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Ataxia | 0 | | 2015 | 2020 | 6.8 | low | 0 | 0 | 0 | 0 | 4 | 0 |
Atherogenesis | 0 | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Atherosclerosis | 0 | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Atrioventricular Nodal Re-Entrant Tachycardia | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Autoimmune Diabetes | 0 | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Benign Neoplasms | 0 | | 2007 | 2021 | 10.0 | low | 1 | 0 | 0 | 1 | 0 | 1 |
Blood Poisoning | 0 | | 2017 | 2017 | 7.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
Blood Pressure, High | 0 | | 2004 | 2007 | 18.5 | low | 0 | 0 | 0 | 2 | 0 | 0 |
Body Weight | 0 | | 1994 | 2017 | 19.5 | low | 0 | 0 | 4 | 5 | 1 | 0 |
Bovine Spongiform Encephalopathy | 0 | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Brain Diseases | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Brain Disorders | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Breast Cancer | 0 | | 2007 | 2007 | 17.0 | low | 2 | 0 | 0 | 2 | 0 | 0 |
Breast Neoplasms | 0 | | 2007 | 2007 | 17.0 | low | 2 | 0 | 0 | 2 | 0 | 0 |
Bronze Diabetes | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Cachexia | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Cancer of Colon | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Cancer of Liver | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Cancer of Pancreas | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Cancer of Prostate | 0 | | 2007 | 2007 | 17.0 | low | 2 | 0 | 0 | 2 | 0 | 0 |
Cancer of Stomach | 0 | | 2007 | 2007 | 17.0 | low | 2 | 0 | 0 | 2 | 0 | 0 |
Cancer of the Urinary Tract | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Carcinoma, Hepatocellular | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Carcinoma, Transitional Cell | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Cardiac Remodeling, Ventricular | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Cardiometabolic Syndrome | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Cardiomyopathies | 0 | | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Cardiomyopathies, Primary | 0 | | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Cardiovascular Diseases | 0 | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Cardiovascular Stroke | 0 | | 1991 | 2008 | 24.5 | low | 0 | 0 | 1 | 1 | 0 | 0 |
Carditis | 0 | | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
Cells, Neoplasm Circulating | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Central Hypothyroidism | 0 | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Chemical and Drug Induced Liver Injury | 0 | | 1997 | 1998 | 26.5 | low | 0 | 0 | 2 | 0 | 0 | 0 |
Cirrhosis | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Cirrhosis, Liver | 0 | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Colonic Neoplasms | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Complication, Postoperative | 0 | | 2007 | 2007 | 17.0 | low | 2 | 0 | 0 | 2 | 0 | 0 |
Deficiency, Vitamin E | 0 | | 1997 | 2010 | 20.8 | low | 0 | 0 | 2 | 2 | 0 | 0 |
Delayed Effects, Prenatal Exposure | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Dementia | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Dermatoses | 0 | | 1990 | 1990 | 34.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Diabetes Mellitus, Adult-Onset | 0 | | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Diabetes Mellitus, Type 1 | 0 | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Diabetes Mellitus, Type 2 | 0 | | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Diathesis | 0 | | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Disease Exacerbation | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Disease Models, Animal | 0 | | 1991 | 2019 | 15.9 | low | 1 | 0 | 2 | 9 | 6 | 0 |
Electron Transport Chain Deficiencies, Mitochondrial | 0 | | 2009 | 2020 | 8.6 | low | 0 | 0 | 0 | 1 | 6 | 0 |
Encephalomyelitis, Subacute Necrotizing | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Encephalomyopathies, Mitochondrial | 0 | | 2013 | 2019 | 7.0 | low | 0 | 0 | 0 | 0 | 3 | 0 |
Enterovirus Infections | 0 | | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
Experimental Hepatoma | 0 | | 1997 | 1999 | 25.7 | low | 0 | 0 | 3 | 0 | 0 | 0 |
Experimental Neoplasms | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Experimental Radiation Injuries | 0 | | 1981 | 1985 | 41.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
Fatty Liver | 0 | | 2009 | 2010 | 14.5 | low | 0 | 0 | 0 | 2 | 0 | 0 |
Fatty Liver, Nonalcoholic | 0 | | 2007 | 2012 | 14.5 | low | 1 | 0 | 0 | 1 | 1 | 0 |
Fibrosis | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Focal Segmental Glomerulosclerosis | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Fukuhara Disease | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Gastric Outlet Obstruction | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Genetic Predisposition | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Glial Cell Tumors | 0 | | 1984 | 2007 | 28.5 | low | 1 | 1 | 0 | 1 | 0 | 0 |
Glioma | 0 | | 1984 | 2007 | 28.5 | low | 1 | 1 | 0 | 1 | 0 | 0 |
Glomerulosclerosis, Focal Segmental | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
HbS Disease | 0 | | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Hearing Loss, Noise-Induced | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Heart Disease, Ischemic | 0 | | 1992 | 2008 | 24.0 | low | 0 | 0 | 1 | 1 | 0 | 0 |
Helicobacter Infections | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Hemochromatosis | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Hemorrhagic Shock | 0 | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Hepatocellular Carcinoma | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Huntington Disease | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Hypertension | 0 | | 2004 | 2007 | 18.5 | low | 0 | 0 | 0 | 2 | 0 | 0 |
Hyperthyroid | 0 | | 2002 | 2004 | 21.0 | low | 0 | 0 | 0 | 3 | 0 | 0 |
Hyperthyroidism | 0 | | 2002 | 2004 | 21.0 | low | 0 | 0 | 0 | 3 | 0 | 0 |
Hypothyroidism | 0 | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Infection, Postoperative Wound | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Infections, Helicobacter | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Infections, Listeria | 0 | | 1981 | 1981 | 43.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
Infections, Plasmodium | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Inflammation | 0 | | 2007 | 2010 | 15.5 | low | 0 | 0 | 0 | 2 | 0 | 0 |
Injury, Myocardial Reperfusion | 0 | | 1991 | 2008 | 23.8 | low | 0 | 0 | 2 | 3 | 0 | 0 |
Innate Inflammatory Response | 0 | | 2007 | 2010 | 15.5 | low | 0 | 0 | 0 | 2 | 0 | 0 |
Insulin Resistance | 0 | | 2009 | 2010 | 14.5 | low | 0 | 0 | 0 | 2 | 0 | 0 |
Insulin Sensitivity | 0 | | 2009 | 2010 | 14.5 | low | 0 | 0 | 0 | 2 | 0 | 0 |
Invasiveness, Neoplasm | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Iron Overload | 0 | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Ischemia | 0 | | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
Lactic Acidosis | 0 | | 2016 | 2018 | 7.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
Leanness | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Leigh Disease | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Liver Cirrhosis | 0 | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Liver Diseases | 0 | | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Liver Diseases, Alcoholic | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Liver Dysfunction | 0 | | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Liver Failure, Acute | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Liver Neoplasms | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Liver Steatosis | 0 | | 2009 | 2010 | 14.5 | low | 0 | 0 | 0 | 2 | 0 | 0 |
Local Neoplasm Recurrence | 0 | | 2007 | 2007 | 17.0 | low | 2 | 0 | 0 | 2 | 0 | 0 |
Malaria | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Metabolic Syndrome | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Mitochondrial Diseases | 0 | | 2009 | 2020 | 8.6 | low | 0 | 0 | 0 | 1 | 6 | 0 |
Morbid Obesity | 0 | | 2007 | 2007 | 17.0 | low | 2 | 0 | 0 | 2 | 0 | 0 |
Muscle Weakness | 0 | | 2015 | 2020 | 6.8 | low | 0 | 0 | 0 | 0 | 4 | 0 |
Muscular Weakness | 0 | | 2015 | 2020 | 6.8 | low | 0 | 0 | 0 | 0 | 4 | 0 |
Myocardial Infarction | 0 | | 1991 | 2008 | 24.5 | low | 0 | 0 | 1 | 1 | 0 | 0 |
Myocardial Ischemia | 0 | | 1992 | 2008 | 24.0 | low | 0 | 0 | 1 | 1 | 0 | 0 |
Myocarditis | 0 | | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
Necrosis | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Neoplasms | 0 | | 2007 | 2021 | 10.0 | low | 1 | 0 | 0 | 1 | 0 | 1 |
Nephritis | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Nerve Degeneration | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Non-alcoholic Fatty Liver Disease | 0 | | 2007 | 2012 | 14.5 | low | 1 | 0 | 0 | 1 | 1 | 0 |
Obesity | 0 | | 2007 | 2010 | 15.3 | low | 1 | 0 | 0 | 3 | 0 | 0 |
Obesity, Morbid | 0 | | 2007 | 2007 | 17.0 | low | 2 | 0 | 0 | 2 | 0 | 0 |
Orphan Diseases | 0 | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Pancreatic Neoplasms | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Postoperative Complications | 0 | | 2007 | 2007 | 17.0 | low | 2 | 0 | 0 | 2 | 0 | 0 |
Poultry Diseases | 0 | | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Pregnancy | 0 | | 2007 | 2018 | 11.2 | low | 1 | 0 | 0 | 2 | 2 | 0 |
Prostatic Neoplasms | 0 | | 2007 | 2007 | 17.0 | low | 2 | 0 | 0 | 2 | 0 | 0 |
Rheumatoid Arthritis | 0 | | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
Sensitivity and Specificity | 0 | | 1998 | 2008 | 20.3 | low | 0 | 0 | 1 | 2 | 0 | 0 |
Sepsis | 0 | | 2017 | 2017 | 7.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
Skin Aging | 0 | | 1990 | 1990 | 34.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Skin Diseases | 0 | | 1990 | 1990 | 34.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Stomach Neoplasms | 0 | | 2007 | 2007 | 17.0 | low | 2 | 0 | 0 | 2 | 0 | 0 |
Tachycardia, Ventricular | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Thrombocytopenia | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Thrombopenia | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Thyroid Diseases | 0 | | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
Specific lipidome signatures in central nervous system from methionine-restricted mice.Journal of proteome research, , Jun-07, Volume: 12, Issue:6, 2013
The role of alpha-tocopherol in motor hypofunction with aging in alpha-tocopherol transfer protein knockout mice as assessed by oxidative stress biomarkers.The Journal of nutritional biochemistry, , Volume: 21, Issue:1, 2010
Prolonged intake of coenzyme Q10 impairs cognitive functions in mice.The Journal of nutrition, , Volume: 139, Issue:10, 2009
Coenzyme Q supports distinct developmental processes in Caenorhabditis elegans.Mechanisms of ageing and development, , Volume: 130, Issue:3, 2009
Life-long supplementation with a low dosage of coenzyme Q10 in the rat: effects on antioxidant status and DNA damage.BioFactors (Oxford, England), , Volume: 25, Issue:1-4, 2005
Coenzyme Q10 protects from aging-related oxidative stress and improves mitochondrial function in heart of rats fed a polyunsaturated fatty acid (PUFA)-rich diet.The journals of gerontology. Series A, Biological sciences and medical sciences, , Volume: 60, Issue:8, 2005
Structural damage induced by peroxidation may account for functional impairment of heavy synaptic mitochondria.Free radical research, , Volume: 36, Issue:4, 2002
Extension of life-span in Caenorhabditis elegans by a diet lacking coenzyme Q.Science (New York, N.Y.), , Jan-04, Volume: 295, Issue:5552, 2002
Aging. Dietary advice on Q.Science (New York, N.Y.), , Jan-04, Volume: 295, Issue:5552, 2002
Coenzymes Q9 and Q10, vitamin E and peroxidation in rat synaptic and non-synaptic occipital cerebral cortex mitochondria during ageing.Biological chemistry, , Volume: 382, Issue:6, 2001
Mitochondrial coenzyme Q content and aging.BioFactors (Oxford, England), , Volume: 9, Issue:2-4, 1999
HMG CoA reductase inhibitor accelerates aging effect on diaphragm mitochondrial respiratory function in rats.Biochemistry and molecular biology international, , Volume: 46, Issue:5, 1998
Dietary restriction affects antioxidant levels in rat liver mitochondria during ageing.Molecular aspects of medicine, , Volume: 18 Suppl, 1997
[Coenzyme Q9 biosynthesis in the aging myocardium after ischemia and reperfusion].Cardiologia (Rome, Italy), , Volume: 37, Issue:10, 1992
Exogenous administration of coenzyme Q10 restores mitochondrial oxygen consumption in the aged mouse brain.Mechanisms of ageing and development, , Volume: 134, Issue:11-12
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.Hepatology (Baltimore, Md.), , Volume: 52, Issue:3, 2010
Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q?Journal of applied physiology (Bethesda, Md. : 1985), , Volume: 107, Issue:3, 2009
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
Insensitivity of ubiquinone biosynthesis in glioblastoma cells to an epileptogenic drug, U18666A.Journal of neurochemistry, , Volume: 43, Issue:5, 1984
Effect of cold-induced hyperthyroidism on H2O2 production and susceptibility to stress conditions of rat liver mitochondria.Free radical biology & medicine, , Feb-01, Volume: 36, Issue:3, 2004
Effect of thyroid state on susceptibility to oxidants and swelling of mitochondria from rat tissues.Free radical biology & medicine, , Sep-01, Volume: 35, Issue:5, 2003
Effect of ischemia-reperfusion on heart mitochondria from hyperthyroid rats.Cardiovascular research, , Volume: 56, Issue:1, 2002
High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.Hepatology (Baltimore, Md.), , Volume: 52, Issue:3, 2010
Altered skeletal muscle insulin signaling and mitochondrial complex II-III linked activity in adult offspring of obese mice.American journal of physiology. Regulatory, integrative and comparative physiology, , Volume: 297, Issue:3, 2009
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
DDIT3 Directs a Dual Mechanism to Balance Glycolysis and Oxidative Phosphorylation during Glutamine Deprivation.Advanced science (Weinheim, Baden-Wurttemberg, Germany), , Volume: 8, Issue:11, 2021
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.Hepatology (Baltimore, Md.), , Volume: 52, Issue:3, 2010
Altered skeletal muscle insulin signaling and mitochondrial complex II-III linked activity in adult offspring of obese mice.American journal of physiology. Regulatory, integrative and comparative physiology, , Volume: 297, Issue:3, 2009
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
A family segregating lethal neonatal coenzyme QJournal of inherited metabolic disease, , Volume: 41, Issue:4, 2018
A single nucleotide polymorphism in COQ9 affects mitochondrial and ovarian function and fertility in Holstein cows.Biology of reproduction, , 03-01, Volume: 96, Issue:3, 2017
Altered skeletal muscle insulin signaling and mitochondrial complex II-III linked activity in adult offspring of obese mice.American journal of physiology. Regulatory, integrative and comparative physiology, , Volume: 297, Issue:3, 2009
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
Rapid neonatal weight gain in rats results in a renal ubiquinone (CoQ) deficiency associated with premature death.Mechanisms of ageing and development, , Volume: 128, Issue:11-12
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
Determination of coenzyme Q10 and Q9 in vegetable oils.Journal of agricultural and food chemistry, , Aug-13, Volume: 56, Issue:15, 2008
Analytical method for ubiquinone-9 and ubiquinone-10 in rat tissues by liquid chromatography/turbo ion spray tandem mass spectrometry with 1-alkylamine as an additive to the mobile phase.Analytical biochemistry, , Mar-01, Volume: 338, Issue:1, 2005
Determination of ubiquinone-9 and 10 levels in rat tissues and blood by high-performance liquid chromatography with ultraviolet detection.Journal of chromatographic science, , Volume: 36, Issue:5, 1998
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
A rare case of primary coenzyme Q10 deficiency due to COQ9 mutation.Journal of pediatric endocrinology & metabolism : JPEM, , Jan-28, Volume: 33, Issue:1, 2020
A family segregating lethal neonatal coenzyme QJournal of inherited metabolic disease, , Volume: 41, Issue:4, 2018
Disruption of the human COQ5-containing protein complex is associated with diminished coenzyme Q10 levels under two different conditions of mitochondrial energy deficiency.Biochimica et biophysica acta, , Volume: 1860, Issue:9, 2016
The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene.EMBO molecular medicine, , Volume: 7, Issue:5, 2015
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
A rare case of primary coenzyme Q10 deficiency due to COQ9 mutation.Journal of pediatric endocrinology & metabolism : JPEM, , Jan-28, Volume: 33, Issue:1, 2020
Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease.EBioMedicine, , Volume: 42, 2019
A family segregating lethal neonatal coenzyme QJournal of inherited metabolic disease, , Volume: 41, Issue:4, 2018
Disruption of the human COQ5-containing protein complex is associated with diminished coenzyme Q10 levels under two different conditions of mitochondrial energy deficiency.Biochimica et biophysica acta, , Volume: 1860, Issue:9, 2016
The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene.EMBO molecular medicine, , Volume: 7, Issue:5, 2015
Altered redox status of coenzyme Q9 reflects mitochondrial electron transport chain deficiencies in Caenorhabditis elegans.Mitochondrion, , Volume: 11, Issue:1, 2011
A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease.American journal of human genetics, , Volume: 84, Issue:5, 2009
Mechanisms of protection by S-allylmercaptocysteine against acetaminophen-induced liver injury in mice.Japanese journal of pharmacology, , Volume: 78, Issue:2, 1998
Cytosolic NADPH-UQ reductase-linked recycling of cellular ubiquinol: its protective effect against carbon tetrachloride hepatotoxicity in rat.Molecular aspects of medicine, , Volume: 18 Suppl, 1997
[Antioxidant activity of ubiquinone-9 and its combinations with vitamin E and sodium selenite in toxic lesions of the liver].Farmakologiia i toksikologiia, , Volume: 52, Issue:1
Coenzyme Q metabolism is disturbed in high fat diet-induced non-alcoholic fatty liver disease in rats.International journal of molecular sciences, , Volume: 13, Issue:2, 2012
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease.EBioMedicine, , Volume: 42, 2019
β-RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in EMBO molecular medicine, , Volume: 11, Issue:1, 2019
Dysfunctional Coq9 protein causes predominant encephalomyopathy associated with CoQ deficiency.Human molecular genetics, , Mar-15, Volume: 22, Issue:6, 2013
A rare case of primary coenzyme Q10 deficiency due to COQ9 mutation.Journal of pediatric endocrinology & metabolism : JPEM, , Jan-28, Volume: 33, Issue:1, 2020
A family segregating lethal neonatal coenzyme QJournal of inherited metabolic disease, , Volume: 41, Issue:4, 2018
Disruption of the human COQ5-containing protein complex is associated with diminished coenzyme Q10 levels under two different conditions of mitochondrial energy deficiency.Biochimica et biophysica acta, , Volume: 1860, Issue:9, 2016
The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene.EMBO molecular medicine, , Volume: 7, Issue:5, 2015
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
A rare case of primary coenzyme Q10 deficiency due to COQ9 mutation.Journal of pediatric endocrinology & metabolism : JPEM, , Jan-28, Volume: 33, Issue:1, 2020
Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease.EBioMedicine, , Volume: 42, 2019
A family segregating lethal neonatal coenzyme QJournal of inherited metabolic disease, , Volume: 41, Issue:4, 2018
Disruption of the human COQ5-containing protein complex is associated with diminished coenzyme Q10 levels under two different conditions of mitochondrial energy deficiency.Biochimica et biophysica acta, , Volume: 1860, Issue:9, 2016
The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene.EMBO molecular medicine, , Volume: 7, Issue:5, 2015
Altered redox status of coenzyme Q9 reflects mitochondrial electron transport chain deficiencies in Caenorhabditis elegans.Mitochondrion, , Volume: 11, Issue:1, 2011
A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease.American journal of human genetics, , Volume: 84, Issue:5, 2009
Mechanisms of protection by S-allylmercaptocysteine against acetaminophen-induced liver injury in mice.Japanese journal of pharmacology, , Volume: 78, Issue:2, 1998
Cytosolic NADPH-UQ reductase-linked recycling of cellular ubiquinol: its protective effect against carbon tetrachloride hepatotoxicity in rat.Molecular aspects of medicine, , Volume: 18 Suppl, 1997
[Antioxidant activity of ubiquinone-9 and its combinations with vitamin E and sodium selenite in toxic lesions of the liver].Farmakologiia i toksikologiia, , Volume: 52, Issue:1
Coenzyme Q metabolism is disturbed in high fat diet-induced non-alcoholic fatty liver disease in rats.International journal of molecular sciences, , Volume: 13, Issue:2, 2012
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
Treatment with coenzyme Q10, omega-3-polyunsaturated fatty acids and their combination improved bioenergetics and levels of coenzyme Q9 and Q10 in skeletal muscle mitochondria in experimental model of arthritis.Physiological research, , 11-29, Volume: 70, Issue:5, 2021
Combined methotrexate and coenzyme Q₁₀ therapy in adjuvant-induced arthritis evaluated using parameters of inflammation and oxidative stress.Acta biochimica Polonica, , Volume: 57, Issue:3, 2010
A rare case of primary coenzyme Q10 deficiency due to COQ9 mutation.Journal of pediatric endocrinology & metabolism : JPEM, , Jan-28, Volume: 33, Issue:1, 2020
A family segregating lethal neonatal coenzyme QJournal of inherited metabolic disease, , Volume: 41, Issue:4, 2018
Disruption of the human COQ5-containing protein complex is associated with diminished coenzyme Q10 levels under two different conditions of mitochondrial energy deficiency.Biochimica et biophysica acta, , Volume: 1860, Issue:9, 2016
The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene.EMBO molecular medicine, , Volume: 7, Issue:5, 2015
A single nucleotide polymorphism in COQ9 affects mitochondrial and ovarian function and fertility in Holstein cows.Biology of reproduction, , 03-01, Volume: 96, Issue:3, 2017
In vivo antioxidative activity of a quantified Pueraria lobata root extract.Journal of ethnopharmacology, , Jan-08, Volume: 127, Issue:1, 2010
Altered skeletal muscle insulin signaling and mitochondrial complex II-III linked activity in adult offspring of obese mice.American journal of physiology. Regulatory, integrative and comparative physiology, , Volume: 297, Issue:3, 2009
Prolonged intake of coenzyme Q10 impairs cognitive functions in mice.The Journal of nutrition, , Volume: 139, Issue:10, 2009
Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice.Biochimica et biophysica acta, , Volume: 1762, Issue:6, 2006
Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension.Life sciences, , Jan-23, Volume: 74, Issue:10, 2004
Effect of dietary supplementation with the pyridoindole antioxidant stobadine on antioxidant state and ultrastructure of diabetic rat myocardium.Acta diabetologica, , Volume: 37, Issue:3, 2000
Dietary iron overload inhibits carbon tetrachloride-induced promotion in chemical hepatocarcinogenesis: effects on cell proliferation, apoptosis, and antioxidation.Journal of hepatology, , Volume: 30, Issue:4, 1999
Studies on genotoxic effects of iron overload and alcohol in an animal model of hepatocarcinogenesis.Journal of hepatology, , Volume: 27, Issue:3, 1997
Effects of ethanol, lovastatin and coenzyme Q10 treatment on antioxidants and TBA reactive material in liver of rats.Molecular aspects of medicine, , Volume: 15 Suppl, 1994
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
Effects of various squalene epoxides on coenzyme Q and cholesterol synthesis.Biochimica et biophysica acta, , Volume: 1841, Issue:7, 2014
In vivo antioxidative activity of a quantified Pueraria lobata root extract.Journal of ethnopharmacology, , Jan-08, Volume: 127, Issue:1, 2010
The effect of antioxidant treatment and NOS inhibition on the incidence of ischemia-induced arrhythmias in the diabetic rat heart.Physiological research, , Volume: 57 Suppl 2, 2008
Study of potential systemic oxidative stress animal models for the evaluation of antioxidant activity: status of lipid peroxidation and fat-soluble antioxidants.The Journal of pharmacy and pharmacology, , Volume: 59, Issue:1, 2007
Insulin-like growth factor I (IGF-1) supplementation prevents diabetes-induced alterations in coenzymes Q9 and Q10.Acta diabetologica, , Volume: 40, Issue:2, 2003
Effect of dietary supplementation with the pyridoindole antioxidant stobadine on antioxidant state and ultrastructure of diabetic rat myocardium.Acta diabetologica, , Volume: 37, Issue:3, 2000
β-RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in EMBO molecular medicine, , Volume: 11, Issue:1, 2019
Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease.EBioMedicine, , Volume: 42, 2019
The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene.EMBO molecular medicine, , Volume: 7, Issue:5, 2015
Neuronal marker recovery after Simvastatin treatment in dementia in the rat brain: in vivo magnetic resonance study.Behavioural brain research, , May-01, Volume: 284, 2015
Hypothermia reduces resuscitation fluid volumes required to maintain blood pressure in a rat hemorrhagic shock model.The journal of trauma and acute care surgery, , Volume: 72, Issue:1, 2012
Altered redox status of coenzyme Q9 reflects mitochondrial electron transport chain deficiencies in Caenorhabditis elegans.Mitochondrion, , Volume: 11, Issue:1, 2011
High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.Hepatology (Baltimore, Md.), , Volume: 52, Issue:3, 2010
Altered skeletal muscle insulin signaling and mitochondrial complex II-III linked activity in adult offspring of obese mice.American journal of physiology. Regulatory, integrative and comparative physiology, , Volume: 297, Issue:3, 2009
Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts.American journal of physiology. Heart and circulatory physiology, , Volume: 294, Issue:5, 2008
Simvastatin decreased coenzyme Q in the left ventricle and skeletal muscle but not in the brain and liver in L-NAME-induced hypertension.Physiological research, , Volume: 56 Suppl 2, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
Coenzyme Q and protein/lipid oxidation in a BSE-infected transgenic mouse model.Free radical biology & medicine, , Jun-01, Volume: 42, Issue:11, 2007
Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice.Biochimica et biophysica acta, , Volume: 1762, Issue:6, 2006
Insulin-like growth factor I (IGF-1) supplementation prevents diabetes-induced alterations in coenzymes Q9 and Q10.Acta diabetologica, , Volume: 40, Issue:2, 2003
Enhanced mitochondrial testicular antioxidant capacity in Goto-Kakizaki diabetic rats: role of coenzyme Q.American journal of physiology. Cell physiology, , Volume: 281, Issue:3, 2001
Studies on genotoxic effects of iron overload and alcohol in an animal model of hepatocarcinogenesis.Journal of hepatology, , Volume: 27, Issue:3, 1997
[Cardioprotective effect of combined use of coenzyme Q9 and cyclohexyladenosine in ischemia, reperfusion and acute myocardial infarction].Kardiologiia, , Volume: 31, Issue:6, 1991
Rapid neonatal weight gain in rats results in a renal ubiquinone (CoQ) deficiency associated with premature death.Mechanisms of ageing and development, , Volume: 128, Issue:11-12
Calcium-dependent mitochondrial permeability transition is augmented in the kidney of Goto-Kakizaki diabetic rat.Diabetes/metabolism research and reviews, , Volume: 20, Issue:2
High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.Hepatology (Baltimore, Md.), , Volume: 52, Issue:3, 2010
Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q?Journal of applied physiology (Bethesda, Md. : 1985), , Volume: 107, Issue:3, 2009
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
Insensitivity of ubiquinone biosynthesis in glioblastoma cells to an epileptogenic drug, U18666A.Journal of neurochemistry, , Volume: 43, Issue:5, 1984
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
Effect of cold-induced hyperthyroidism on H2O2 production and susceptibility to stress conditions of rat liver mitochondria.Free radical biology & medicine, , Feb-01, Volume: 36, Issue:3, 2004
Effect of thyroid state on susceptibility to oxidants and swelling of mitochondria from rat tissues.Free radical biology & medicine, , Sep-01, Volume: 35, Issue:5, 2003
Effect of ischemia-reperfusion on heart mitochondria from hyperthyroid rats.Cardiovascular research, , Volume: 56, Issue:1, 2002
High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.Hepatology (Baltimore, Md.), , Volume: 52, Issue:3, 2010
Altered skeletal muscle insulin signaling and mitochondrial complex II-III linked activity in adult offspring of obese mice.American journal of physiology. Regulatory, integrative and comparative physiology, , Volume: 297, Issue:3, 2009
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
Dietary iron overload inhibits carbon tetrachloride-induced promotion in chemical hepatocarcinogenesis: effects on cell proliferation, apoptosis, and antioxidation.Journal of hepatology, , Volume: 30, Issue:4, 1999
Effects of dietary iron overload on progression in chemical hepatocarcinogenesis.Liver, , Volume: 19, Issue:4, 1999
Studies on genotoxic effects of iron overload and alcohol in an animal model of hepatocarcinogenesis.Journal of hepatology, , Volume: 27, Issue:3, 1997
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
DDIT3 Directs a Dual Mechanism to Balance Glycolysis and Oxidative Phosphorylation during Glutamine Deprivation.Advanced science (Weinheim, Baden-Wurttemberg, Germany), , Volume: 8, Issue:11, 2021
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[Effect of ubiquinone on phospholipid metabolism in radiation injury].Biulleten' eksperimental'noi biologii i meditsiny, , Volume: 99, Issue:4, 1985
[Coenzyme Q9 modification of radiation injury].Radiobiologiia, , Volume: 21, Issue:4, 1981
[Protective and therapeutic properties of the ubiquinones H6CoQ4 and CoQ9 in gamma irradiation].Farmakologiia i toksikologiia, , Volume: 46, Issue:6
[Therapeutic effect of vegetable oils and ubiquinone-9 on radiation injuries].Radiobiologiia, , Volume: 25, Issue:1
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
The role of alpha-tocopherol in motor hypofunction with aging in alpha-tocopherol transfer protein knockout mice as assessed by oxidative stress biomarkers.The Journal of nutritional biochemistry, , Volume: 21, Issue:1, 2010
Study of potential systemic oxidative stress animal models for the evaluation of antioxidant activity: status of lipid peroxidation and fat-soluble antioxidants.The Journal of pharmacy and pharmacology, , Volume: 59, Issue:1, 2007
Protective role of ubiquinone in vitamin E and selenium-deficient plasma membranes.BioFactors (Oxford, England), , Volume: 9, Issue:2-4, 1999
Dietary restriction affects antioxidant levels in rat liver mitochondria during ageing.Molecular aspects of medicine, , Volume: 18 Suppl, 1997
[Determination of adenine nucleotide and inorganic phosphate contents of liver of rats with E-hypovitaminosis and administration of alpha-tocopherol and ubiquinone-9].Ukrainskii biokhimicheskii zhurnal (1978), , Volume: 53, Issue:3
Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts.American journal of physiology. Heart and circulatory physiology, , Volume: 294, Issue:5, 2008
Coenzyme Q9 provides cardioprotection after converting into coenzyme Q10.Journal of agricultural and food chemistry, , Jul-09, Volume: 56, Issue:13, 2008
Effect of ischemia-reperfusion on heart mitochondria from hyperthyroid rats.Cardiovascular research, , Volume: 56, Issue:1, 2002
[Coenzyme Q9 biosynthesis in the aging myocardium after ischemia and reperfusion].Cardiologia (Rome, Italy), , Volume: 37, Issue:10, 1992
[Cardioprotective effect of combined use of coenzyme Q9 and cyclohexyladenosine in ischemia, reperfusion and acute myocardial infarction].Kardiologiia, , Volume: 31, Issue:6, 1991
[no title available]Angewandte Chemie (Weinheim an der Bergstrasse, Germany), , Aug-27, Volume: 119, Issue:34, 2007
Safety/Toxicity (3)
Long-term Use (3)
Article | Year |
Neuronal marker recovery after Simvastatin treatment in dementia in the rat brain: in vivo magnetic resonance study. Behavioural brain research, , May-01, Volume: 284 | 2015 |
Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts. American journal of physiology. Heart and circulatory physiology, , Volume: 294, Issue:5 | 2008 |
The effect of Cyclosporine A chronic administration on the antioxidant pattern of rat liver mitochondria: structural and functional consequences. BioFactors (Oxford, England), , Volume: 18, Issue:1-4 | 2003 |
Pharmacokinetics (1)
Dosage (3)
Article | Year |
A rare case of primary coenzyme Q10 deficiency due to COQ9 mutation. Journal of pediatric endocrinology & metabolism : JPEM, , Jan-28, Volume: 33, Issue:1 | 2020 |
Prolonged intake of coenzyme Q10 impairs cognitive functions in mice. The Journal of nutrition, , Volume: 139, Issue:10 | 2009 |
Life-long supplementation with a low dosage of coenzyme Q10 in the rat: effects on antioxidant status and DNA damage. BioFactors (Oxford, England), , Volume: 25, Issue:1-4 | 2005 |